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ABSTRACT 
A Study of Osteocyte Apoptosis in Mechanically Loaded and Unloaded Murine Tibiae  
Josiah Elihu Kessler 
 
 Previous research has provided evidence in support of apoptotic osteocytes 
playing a role in the bone remodeling process. In this study, we examined the regional 
and quadrantal variations of apoptotic and viable osteocytes in cyclically loaded and 
unloaded samples. Left tibias of C57 Black 6 Taconic mice (C57Bl/6) were cyclically 
loaded for either 2 weeks or 5 weeks, with the right tibias being used as controls. After 
loading, tibias were resected, processed, and then stained using either a TUNEL stain, to 
show apoptotic osteocytes, or a 2.0% methyl green solution, to reveal viable cells. Cross-
sectional images from each tibia were then captured and analyzed in each region (distal, 
midshaft and proximal) and quadrant (cranial, lateral, caudal, and medial) by counting the 
number of osteocytes, both apoptotic and viable, and subsequently calculating the 
percentages and densities of those osteocytes. Individual analysis of each sample group 
showed that the 5 week loaded bones, with the most statistically significant p-values, had 
the most regional variations within the samples, specifically showing decreased apoptotic 
and viable osteocytes in the lateral quadrants. Comparative analysis revealed a 
statistically significant higher percentage and density of apoptotic osteocytes in 5 week 
loaded samples compared to all other samples. This provides further quantitative 
evidence in support of apoptotic osteocytes playing a role in bone remodeling. 
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1. INTRODUCTION 
1.1 Bone Biology 
 
    1.1.1Bone Function and Properties 
 Bone is a connective tissue with unique properties and functions that support the 
human body. With its mineralized extracellular matrix, collagen packed outer shell and 
regions of porous bone, bones, in general, are able to be rigid and strong yet maintain 
some flexibility (Bilezikian, et al. 2008). These properties go hand in hand with its support, 
protection, movement and metabolic functions. Bones come in various shapes and sizes 
throughout the human body and provide the framework that holds the human body up, 
helps it move, and protects the internal organs. For example, bones in the human skull 
help protect the brain while bones that make up the rib cage protect organs like the heart 
and lungs. Bones also act as lever arms that allow the human body to move and perform 
basic tasks. Skeletal muscle is attached to bone via tendons, which is why bones are able 
to act as a mechanical support system for muscle activity that transfers forces and enables 
motion. Acting as a source of inorganic ions like calcium and phosphate, bone 
participates in calcium homeostasis for the human body, releasing minerals into the 
bloodstream as needed (Marieb 2005). Bone is able to perform its versatile mechanical, 
protective and metabolic functions so effectively because of its structure. 
    1.1.2 Bone Structure 
 There are two main types of bone, cortical (compact) and trabecular (cancellous), 
each with their own unique structure. Cortical bone, with a porosity of about 5 to 10 
percent, is the denser of the two and makes up the outermost layer of bone (Figure 1). 
The primary structural unit of cortical bone is the osteon. Each osteon is shaped like a 
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tube and contains concentric layers of packed collagen fibrils called lamellae. Lamellae 
are also cylindrical in shape and are aligned along the long axis of the bone giving it 
some strength. At the junctions of the lamellae lie lacunae or spaces in which mature 
bone cells called osteocytes reside. Canaliculi are small canals that connect lacunae to 
each other as well as to the central Haversian canal containing blood vessels and nerve 
fibers. The processes of the osteocytes also jut into these canaliculi connecting them 
together. Volkmann’s canals are a second type of canal that run perpendicular to 
Haversian canals and connect these Haversion canals to each other as well as to the 
membrane that lines the outer bone surface or periosteum. The endosteum is the thin, 
inner membrane that lines the medullary cavity, whose walls are composed of trabecular 
bone. 
 
Figure 1.  Cortical and trabecular bone structure (International Osteoporosis 
Foundation, 2011) 
 Trabecular bone, with porosities ranging from 50 to 90 percent, is much lighter 
than cortical bone and uses this structure to perform its primarily metabolic functions. 
Trabecular bone is made of trabeculae, beam or strut like structures that are irregularly 
arranged along lines of stress giving the bone a spongy appearance and providing some 
strength and resistance. Trabeculae also contain irregularly arranged lamellae and 
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osteocytes that are connected to each other by processes residing in canaliculi.  Due to its 
porous nature, many of the voids in trabecular bone are filled with marrow where blood 
cells are produced (Marieb 2005). 
    1.1.3 Bone Matrix 
 Bone is primarily made up of bone matrix. Bone matrix is strengthened by 
calcium deposits and is made up of organic and inorganic components. Approximately 
90% of the organic extracellular components are type I collagen and 10% are 
proteoglycans, numerous proteins and cellular components. The large amount of collagen 
seen in the organic part of the matrix is what helps give bones their elasticity and tensile 
strength. The inorganic part of the matrix is made of hydroxyapatite, which accounts for 
most of the weight in the matrix and thus is responsible for providing much of the 
hardness and compressive strength seen in bone. When bone is being created, osteoblasts 
secrete bone matrix around blood vessels. As the matrix hardens, these cells get trapped 
inside and develop into osteocytes. Even though this formed bone matrix is hard and 
impervious to nutrients, the canaliculi and cell to cell communication via gap junctions 
allow the containing cells to receive the nutrients needed. 
    1.1.4 Bone Cells 
 Bones contain four different cell types within: osteoblasts, osteocytes, osteoclasts 
and bone lining cells. Osteoblasts, osteoclasts and bone lining cells can be found on the 
surfaces of bone while osteocytes are embedded within the bone matrix. 
 Osteoblasts, much like osteocytes and bone lining cells, develop from 
osteoprogenitor cells. Osteoblasts are mononuclear, cuboidal, fully differentiated cells 
whose primary job is to create bone matrix by laying down osteoid. Osteoid is produced 
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at a rate of 1 micron per day. About ten to twenty percent of these osteoblasts will 
become embedded in the bone matrix (Noble 2008). 
 Opposite of osteoblasts are osteoclasts, large, multinucleated bone cells which 
resorb bone rather than lay down new bone. Osteoclasts resorb bone at a rate of about 
tens of microns per day by demineralizing the bone and dissolving the present collagen 
(Martin, et al. 1998). There are two important areas of its plasma membrane, the ruffled 
border and the clear zone. The ruffled border is the central area in the plasma membrane 
where bone resorption takes place. The clear zone is the area of the membrane that 
surrounds the ruffled border and attaches the osteoclast to the bone matrix (Bilezikian, et 
al. 2008). 
 Osteocytes, are the most common cell type, of the four, found in bone; there are 
about 10 times more osteocytes than there are osteoblasts (Aarden, et al. 1994). 
Osteocytes, as previously mentioned, are formed when an osteoblast gets embedded in 
the bone matrix it secretes. When the osteoblast first starts getting embedded in the 
matrix, that part of the matrix is still relatively weak. As other osteoblasts continue laying 
down bone, the embedded osteoblast gets further secured in the matrix as the matrix 
starts to calcify and the osteoblast starts changing shape and reducing in size. 
Specifically, the number of organelles is reduced in the mitochondria, golgi apparatus and 
endoplasmic reticulum (Bell, et al. 2008). At this point, the osteoblast becomes an 
osteocyte. Osteocytes are stellate shaped and are located within lacunae and communicate 
with other cells extracellularly via the canaliculi throughout the matrix and intracellularly 
with other osteocytes via cytoplasmic processes utilizing gap junctions (Aarden, et al. 
1994). Osteocytes, in response to loading, can produce a number of molecules that may 
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be involved in osteogenesis or may undergo apoptosis, or cell death, if a lot of localized 
remodeling is occurring. It has been thought that osteocytes may also be involved in 
targeting osteoblasts and osteoclasts for bone remodeling due to sensing applied loads 
and their related strains (Noble 2003). 
 A second type of cell that can result from osteoblasts are bone lining cells. Theses 
long, elongated cells are inactive and neither lay down bone nor resorb it and are spread 
out on newly formed surfaces of bone after remodeling has stopped. The cells will detach 
when osteoclasts start resorbing bone. Bone lining cells are also thought to regulate the 
influx and outflux of various ions (Bilezikian, et al. 2008).  
1.2 Bone Remodeling 
 
    1.2.1 Modeling vs. Remodeling 
  Over the human life span there are two very important processes that occur 
related to bone. The first, modeling, takes place when humans are young and involves 
creating bone. This phase is all about bone formation over bone resorption as it is more 
important to build and shape the mineralized tissue when there is little. For bone 
modeling, bone can be resorbed in some places and placed down in others, independent 
of each other (Martin, et al. 1998). The second process, remodeling, involves maintaining 
and repairing these bones and occurs over the entire human life span by removing and 
replacing a fraction of the bone every year; microscopic damage caused by fatigue or 
loading is repaired and prevented by bone remodeling. Unlike bone modeling, bone 
remodeling doesn’t usually affect the shape or size of the bone. In this phase, bone 
resorption and bone formation are coupled so that all the bone taken away can be equally 
replaced by new bone at the same site. This is a local event in which local factors recruit 
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and regulate the necessary cells and is carried out by a groups of osteoblasts and 
osteoclasts called a basic multicellular units or BMUs (Bilezikian, et al. 2008). A BMU, 
shown in Figure 2, consists of about ten osteoclasts, hundreds of osteoblasts and a central 
capillary to supply nutrients. BMUs go through a few stages throughout the remodeling 
process, shown in Figure 3.  
 
Figure 2.  The structure of a Basic Multicellular Unit (BMU):  The upper portion 
shows a longitudinal section through an active BMU while the lower portion 
displays a cartoon showing how the osteoclasts and osteoblasts work.  The blue 
osteoclasts can be seen resorbing bone, while the green osteoblasts follow laying 
down unmineralized osteoid, stained blue, that slowly becomes mineralized, which 
can be seen stained black. (Robling, et al. 2006). 
    1.2.2 Process 
 The first stage, activation, happens when osteoclasts are signaled to form by local 
factors and start resorbing bone. This leads to the resorption stage where osteoclasts, at 
the front of the BMU, start removing bone moving forward at rate of about 40 
micrometers per day; osteoclasts remove bone in a cone like shape for cortical bone and 
forms flat grooves if removing bone on a bone surface or in trabecular bone. The 
diameter of the region dug out by osteoclasts reaches about 250 to 300 micrometers, 
defining the approximate size of the secondary osteon to be formed (Robling, et al. 
2006). After resorption comes the reversal stage, a ten day transition period, in which a 
cement line is formed on top of the resorption space by mononuclear cells and connects 
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the old bone to the new bone that will be put down on top. Next, is the formation stage 
and occurs much slower than the resorption stage. Formation takes about 3 months to 
complete while it took only 3 weeks for the resorption phase. During this time, 
osteoblasts lay down osteoid, unmineralized matrix, upon which will be mineralized over 
time. Each BMU leaves space for a Haversion canal in the bone so nutrients can be 
delivered. The last stage is the resting stage, or quiescence, and involves the osteoblasts 
either becoming embedded in the matrix to form osteocytes or becoming bone lining 
cells, thus finishing the completion of a secondary osteon (Martin, et al. 1998). 
 
Figure 3.  The cycle of bone remodeling (Hill 1998). 
    1.2.3 Purpose 
 The structure and function of bone are recognized as entities that work hand in 
hand. Bones are not just able to handle the normal loading conditions that occur every 
day but are able to adjust to any additional stresses that may be placed. This thought 
process was described by Julius Wolff. Wolff’s Law stated that bones will alter their 
structure in response to a loading condition in order to better accommodate that load or 
lack thereof (Bilezikian, et al. 2008). This describes what we see in bone remodeling. The 
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loading of bone, and subsequent damage caused, as well as the disuse of bone has major 
effects over the structure of the bone and is responsible for remodeling taking place.   
Disuse of bone causes more bone to be removed with not as much bone being 
formed during the remodeling process resulting in an overall loss of bone mass. 
Mechanical loading on the other can cause more bone to be formed in response. As bone 
becomes damaged, osteoclasts are signaled to remove the damaged bone and osteoblasts 
are signaled to lay down the necessary new bone. A study involving the loading of rat 
forelimbs showed that increasing the loading frequency increased bone formation 
(Robling, et al. 2006). So, the loading conditions, including the amount of load, the 
frequency it is applied and the duration of the load, all play a role in the bone remodeling 
process. Overloading bone can cause microdamage within the bone, which bone 
remodeling will try to repair. However, if the bone is overloaded too much, damage may 
be incurred faster than the bone can repair it. If this continues, larger microcracks can 
form and propagate causing stress fractures.    
    1.2.4 Fatigue Microdamage 
 Throughout our lives, our bones are constantly being subjected to multiple loads 
every day. Much like any other structure, as these loads are applied over and over again, 
fatigue microdamage occurs within the bone and is seen visually as microcracks. Frost 
was the first one to describe microdamage in vivo. Physiologic strains and stresses form 
microdamage and continued loading increases its presence. As the microdamage 
increases, the material and structural properties get further weakened until the 
microcracks grow larger and spread farther leading to the eventual failure of the bone in 
the form of a fatigue fracture. Luckily, bone contains within it the ability to repair this 
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fatigue damage in the form of bone remodeling (Robling, et al. 2006). There is evidence 
that microdamage is associated with recruiting BMUs that will target specific areas where 
bone remodeling is needed. In a study, by Burr and colleagues, remodeling BMUs in 
dogs were shown to be likely associated with fatigue induced microcracks (Burr, et al. 
1985). Another study showed that bone remodeling could be initiated by inducing 
microdamage in rats, which don’t normally remodel their cortical bone (Bentolila, et al. 
1998). These studies indicate a positive correlation between apoptotic osteocytes and the 
recruitment of osteoclasts involved in BMU remodeling by showing that microdamage 
was associated with apoptotic osteocytes and resorption cavities (Robling, et al. 2006). 
For this reason, continued research has been performed regarding osteocyte apoptosis, 
osteocytes as mechanosensors and osteocytes themselves and how they may be involved 
in the remodeling process. 
1.3 The Osteocyte  
 
    1.3.1 Mechanosensors 
As previously described, osteocytes are formed when inactive osteoblasts become 
embedded in the bone matrix. These osteocytes reside within spaces called lacunae that 
are connected to each other by canals called canaliculi. The processes of the osteocytes 
jut into these cancaliculi, creating pathways throughout the bone matrix. Gap junctions 
are present at the ends of these osteocyte processes allowing osteocytes to connect with 
each other. This entire network allows communication between other cells and the 
transfer of nutrients to occur intracellularly as well as extracellularly (Figure 4). Because 
of this large network of connectivity and the sheer amount of osteocytes spread 
throughout the bone matrix, osteocytes are considered the most popular theory in terms of 
10 
 
which bone cell dominates the mechanosensory activity and may be involved in 
activating the bone remodeling process.  
 
Figure 4.  Osteocyte network comprised of osteocyte lacunae (A) that are connected 
via canaliculi (B) to allow for communication within the network.  In the middle, 
resides a Haversian space (C) (Martin, et al. 1998). 
Although many of the inner workings of osteocytes, in regards to their 
mechanosensory capabilities and ability to support or initiate bone remodeling, remain 
unknown, we do know that strain plays an important role. Bones are able to take on 
various loads at different rates and can lay down new bone when the loading felt is 
increased or resorb bone in the case of disuse. Strains in bone are experienced near 
osteocyte lacunae. In theory, cells can feel up to seven times the deformation compared to 
the strain in the tissue itself (Robling, et al. 2006). Because cellular responses within 
bone control the formation and resorption of bone needed for bone remodeling, a 
common theory is that the strains experienced by osteocytes are then translated into 
cellular signals to make this happen, meaning that the osteocytes act as 
mechanotransducers (Bonewald 2006). Various studies have already provided some 
evidence to support this theory. In a study of turkey ulna, loading caused an increase in 
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G6PD, a marker for cell metabolism, in osteocytes relative to local strain magnitudes 
(Skerry, et al. 1989). However, osteocytes are most likely responding to strain derived 
fluid flow rather than strain directly caused by mechanical loading (Bilezikian, et al. 
2008). Osteocyte lacunae may also acts as pumps pushing fluid through the canaliculi 
because of the strain concentrations located adjacent to them (Robling, et al. 2006). 
Another study, showed that nitric oxide (NO), a free radical involved in promoting bone 
formation and inhibiting bone resorption, was generated in osteocytes in response to 
mechanical strain caused by flow-derived shear stress (Bakker et al. 2001). As 
mechanical loads are applied to the bone, interstitial fluid can flow extracellularly 
throughout the bone and osteocytes can use this fluid flow to sense strain information and 
initiate the necessary cellular response (Figure 5). The means in which osteocytes 
actually elicit this cellular response is also unclear. One theory suggests that osteocytes 
control the bone architecture by using the strain experienced in the bone as a feedback 
mechanism to maintain programmed physiological levels of strain (Lanyon 1993; 
Hedgecock, et al. 2007). Another way in which osteocytes may send signals for bone 
resorption or formation is through osteocyte apoptosis (Noble, et al. 1997; Power, et al. 
2002; Bentolila, et al. 1998; Hedgecock, et al. 2007). 
 
Figure 5.  Mechanotransduction in bone (Klein-Nulend, et al. 1995). 
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1.4 Osteocyte Apoptosis 
 
 Apoptosis is a form of programmed cell death or suicide. Apoptosis is a 
physiological form of cell death that occurs in both pathological and healthy bone. The 
process of apoptosis is typically initiated by either proteins released by the mitochondria 
or by activation of a cell surface death receptor in the tumor necrosis factor (TNF) family 
(Hock, et al. 2001). Cells that undergo apoptosis, separate from their neighbors, shrink 
and break into small pieces called apoptotic bodies (Noble 2003). In the nucleus, 
chromatin starts to clump up around the nuclear membrane. As this nuclear DNA is 
continually cleaved, the nucleus disappears and these clumps fill up the cytoplasm until 
eventually breaking the cell into multiple, membrane-bound apoptotic bodies (Bilezikian, 
et al. 2008). As this process is occurring, fluid is leaving the cell which is what causes the 
cell to shrink and separate from its surroundings. These formed apoptotic bodies are 
phagocytosed by specialized cells through a non-inflammatory process (Cardoso, et al. 
2009). In bone, the majority of osteocytes are phagocytosed by osteoclasts near 
resorption sites (Bronckers, et al. 1996). There is another type of cell death, however, and 
that is necrosis. Necrosis typically affects groups of cells, and unlike apoptosis, causes 
their nuclei to swell, spill their cellular contents and attract inflammatory cells. Death by 
necrosis is much faster than apoptosis, is not energy dependent and not as controllable as 
apoptosis (Noble 2003). 
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Figure 6.  The difference between necrotic and apoptotic cells (Gewies 2003). 
    1.4.1 Apoptosis and Bone Remodeling 
 Osteocytes and their connective, canalicular system provide the means to detect 
any changes occurring throughout the bone and initiate bone remodeling to complete the 
necessary repairs. One of the ways in which this may be made possible is through 
apoptotic osteocytes and their role in bone remodeling. Apoptotic osteocytes have been 
shown to lead to increased resorption of bone material, indicating that the death of 
osteocytes is important in osteoclast recruitment during bone remodeling (Henriksen, et 
al. 2009). In one study, Bronckers et al. showed that, in developing bone, the majority of 
apoptotic osteocytes were located at sites with high levels of bone resorption (Bronckers, 
et al. 1996). A study using a rabbit tibial lengthening model showed that apoptotic 
osteocytes were localized in regions with osteoclast activity indicating a close 
relationship between bone remodeling and apoptosis (Li, et al. 2003). 
 Many studies have shown there to be a U-shaped relationship between strain and 
apoptosis seen in osteocytes (Jilka, et al. 2007; Noble, et al. 2003). This means that limbs 
that experience physiological levels of strain show low levels of apoptotic osteocytes. 
Conversely, limbs experiencing unloading or levels of strain high enough to induce 
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microdamage, the two opposite ends of the spectrum, show increased levels of apoptotic 
osteocytes (Jilka, et al. 2007). Thus, microdamage caused by overloading or fatigue 
loading in bone also plays an important role in bone remodeling as well as how it 
connects apoptotic osteocytes to bone remodeling. 
A study by Verborgt et al. was performed to attempt to show a relationship 
between osteocyte apoptosis, bone microdamage and bone resorption. In this study, the 
ulnae of adult rats were fatigue loaded and sections were stained to be able to determine 
which cells were undergoing apoptosis. Apoptotic osteocytes were found in regions 
surrounding microcracks as well as in bone surrounding resorption spaces. However, 
bone that was distant to the microcracks or resorption areas showed no differences when 
compared to the controls. These results were consistent from 1 day after loading to 10 
days after loading. Additionally, increases in empty lacunae and decreases in normal 
osteocytes were observed over time. This study shows a strong correlation between 
microdamage, resorption and apoptotic osteocytes (Verborgt, et al. 2000). A similar study 
performed by Noble et al., attempted to study the role of apoptotic osteocytes on bone 
remodeling related to loading as well. This was done by loading rats with varying levels 
of strain from low to high. The rats had a loading regiment that involved loading them on 
days 1-5 and days 8-12. The rats that were loaded with high enough levels of strain to 
cause some damage resulted in an eight-fold increase in apoptotic osteocytes 7 days after 
the overloading. Next, 14 days after the loading, new Haversian canals were formed. 
Finally, 28 days after the overloading, the infilling of the resorption spaces was seen 
(Noble, et al. 2003). Thus, for this study, the formation of Haversian canals never 
preceded the presence of apoptotic osteocytes, supporting the hypothesis that apoptotic 
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osteocytes may be the mechanism behind bone remodeling. Rats that were loaded with 
low levels of strain also showed higher levels of apoptotic osteocytes relative to 
physiologic levels of strain. This data also seems to support a U-shaped relationship 
between apoptosis in osteocytes and strain and provides evidence that this U-shaped 
relationship may be used to influence bone remodeling (Noble, et al. 2003). 
A study by Hedgecock et al. correlated the regional variability in remodeling with 
the regional variability in osteocyte apoptosis in rabbit tibia midshafts. 
Histomorphometric analyses of the tibias showed that the remodeling parameters were 
the lowest in the cranial quadrant compared to the other quadrants. TUNEL staining was 
also performed in the tibias to see the regional variability of apoptosis within the samples. 
The densities of apoptotic osteocytes found in the cranial quadrant were seen to be lower 
than the densities in the medial quadrant. Also, the densities of osteocyte lacunae, empty 
lacunae and total osteocytes were seen to be higher in the lateral quadrants compared to 
the caudal quadrants. From this data, a strong statistically significant correlation was 
found between the remodeling parameters and the apoptotic osteocyte density. Although 
osteocyte density and lacunar density did not correlate with remodeling parameters like 
the density of apoptotic osteocytes did, the authors suggested that cell viability could be 
another factor added when correlating with remodeling parameters (Hedgecock, et al. 
2007). 
A study by Jessica Chan compared the variations associated with bone 
remodeling factors and densities of apoptotic osteocytes at different regions and 
quadrants within unloaded murine tibias. Bone samples were TUNEL stained to detect 
apoptotic osteocytes and subsequently analyzed. The levels of bone morphogenic protein 
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antagonists, noggin and gremlin, were measured and compared with the amount of 
apoptotic osteocytes found for each quadrant and region within the tibia. This study 
found higher densities of apoptotic osteocytes as well as higher levels of BMP 
antagonists in the midshaft compared to the other regions. There was also found to be a 
positive linear correlation between apoptotic osteocytes and gremlin and a negative linear 
correlation between noggin and percentage of apoptotic osteocytes (Chan 2011). 
1.5 Study Goals (And Previous Studies) 
 
This study continues the work done by Jessica Chan, as previously described, by 
incorporating bones that have been cyclically loaded. The objective of this study is to 
calculate the density of apoptotic and viable osteocytes, filtered by region, quadrant and a 
combination of both, in loaded and unloaded murine cortical bone and attempt to point 
out any statistically significant differences that may be present between the loaded and 
unloaded data.  This study will focus on the tibias taken from the left hind limbs of 
murine specimens, which were mechanically loaded for a time period of either 2 or 5 
weeks.  Densities of osteocytes will be compared between three regions (proximal, 
midshaft and distal) and four anatomic quadrants (cranial, lateral, caudal, and medial) 
present throughout the limb as well as between loaded and unloaded specimens. It is 
hypothesized that osteocyte apoptosis will increase in the loaded limbs for both the 2 
week and 5 week periods as a result of the additional cyclic stress placed on the bones. In 
addition, regional variations in apoptotic osteocytes are expected to be enhanced as a 
result of the increased loading in the limbs for both the 2 week and 5 week periods, with 
the most variation expected to be seen within the 5 week loaded samples due to the 
further loading seen by the samples. 
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2. MATERIALS AND METHODS 
Twelve C57 Black 6 Taconic mice (C57Bl/6) were procured at 7 to 9 weeks of 
age (Taconic, Oxnard, CA), and were housed in microisolation chambers located at the 
California Polytechnic State University vivarium.  A previous study showed that skeletal 
maturity in male and female C57Bl/6 mice is reached between 3 and 6 months of age by 
recording any changes in body weight, length of tibiae, bone density, bone modulus and 
bone composition over a 12 month period (Somerville, et al. 2004).  For this reason, the 
mice used in this study were mechanically loaded once they reached 20 to 25 weeks of 
age and were subsequently sacrificed at around 6 months of age, which means they 
would have reached young adulthood and full skeletal maturity. The loading protocol 
used in this study was approved by the animal care committee. 
2.1 Mechanical Loading 
 Of the twelve mice procured, 4 mice were to be mechanically loaded for a period 
of 2 weeks and the other 8 mice for a period of 5 weeks. For each of the mice, the left 
tibia was mechanically loaded for the designated amount of time while the right tibia was 
used as a control and was not loaded throughout this process; in between loading bouts, 
mice experienced normal loading due to daily motion in their cages. However, due to 
user error, three of the mice had to be prematurely sacrificed and were not used as data in 
this study. Therefore, for this study, 3 mice were mechanically loaded for 2 weeks and 6 
mice were mechanically loaded for 5 weeks using a Bose Enduratec 3220, Enduratec 
signal box and WinTest PCI control system with its relevant WinTest software. In order 
to use the loading equipment the mice needed to be successfully anesthetized beforehand. 
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This was done by placing the mice in an isolation chamber with 4 to 5 percent isoflurane 
being input at 3 liters per minute. This anesthesia equipment can be seen in Figure 7.  
 
Figure 7.  Equipment used to provide isoflurane anesthesia to subjects. 
 Once anesthetized, the mice were placed on the loading fixture and attached to a 
nose cone channeling 2% isoflurane at 1 liter per minute (Verborgt, et al. 2000). The 
loading fixture, as seen in Figure 8, is a ramp that supports most of their body weight 
with a shallow groove indented into the fixture that allows the left hindlimb to be secured 
in one spot so the loading plunger can apply the compressive force.  
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Figure 8.  Loading fixture used to support and secure the mouse during the loading 
process.  
 With the mouse anesthetized and secured in the fixture, the Enduratec and 
WinTest equipment can then be used to cyclically apply a mechanical load to the left 
tibia of each mouse. This is achieved by creating a sinusoidal waveform within the 
WinTest program as can be seen in Figures 9 and 10. 
 
Figure 9.  Interface in WinTest program that shows the cyclical loading procedure. 
20 
 
 
Figure 10.  Sinusoidal waveform observed while running the cyclical loading 
procedure. 
 When the program was run, the subject’s left tibia was ramped up to the preload 
of 0.2 N of compression by displacing the plunger onto the tibia at 0.05 mm per second. 
A sinusoidal waveform cycles the force applied between 1.0 Newton of compression and 
3.2 Newtons of compression at 4 Hz for 1200 cycles before finally ramping back down to 
0.02 Newtons of compression at the end of the mechanical loading. The force values and 
number of cycles were chosen to produce fatigue loading, well below the amount need to 
cause any fracture, within the murine bone (Noble, et al. 2003; Verborgt, et al. 2000). A 
frequency of 4 Hz was chosen to be similar to previous cyclical loading experiments and 
matches normal murine stride frequency (Noble, et al. 2003; Verborgt, et al. 2000; 
Mosley, et al. 1997). After the loading process was complete, each mouse was monitored 
throughout the week to ensure that there were no abnormalities and that neither limb was 
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being favored over the other. The mice loading protocol in its entirety can be seen in 
Appendix A. 
2.2 Specimen Sacrifice, Fixation and Decalcification 
After 2 and 5 weeks of loading, each respective group was sacrificed. Each mouse 
was successfully euthanized via cervical dislocation. After euthanization, each of the 
right and left tibias, were resected and placed in sealed microcentrifuge tubes filled with a 
fixative, Histochoice. Tibiae were then fixated by immersion fixation over the next 3 to 4 
days and subsequently transferred into a decalcifation solution for another 3 to 4 days 
prior to sample embedding. The decalcification solution was composed of 150 grams 
disodium EDTA dehydrate and 15 grams NaOH.  Water was added until the pH of the 
solution reached 7.4 (between 700-800ml), yielding an approximate 15% EDTA solution.  
2.3 Sample Processing  
 
Following sacrifice, tissue immersion fixation, and decalcification, the tissue 
samples were embedded in paraffin wax using the Shandon Excelsior ES system (Thermo 
Fisher Scientific, Waltham, MA).  Next, the embedded tissue blocks were secured on the 
Leica RM2255 rotary microtome (Leica Microsystems, Bannockburn, IL) and seven 
micron thick sections were cut from the block.  Using tweezers, the sections were then 
carefully floated in a warm distilled water bath (Boekel Scientific, Feasterville, PA) and 
subsequently placed onto microscope slides (Thermo Fisher Scientific).  Three sections 
were placed on each microscope slide and were allowed to air dry for 24 hours before the 
staining process.  The full protocols used for the microtome and staining processes are 
listed in Appendices B and C, respectively. To prepare for staining, slides were incubated 
in a 40˚C oven for twenty to thirty minutes or until the paraffin wax became more 
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transparent and malleable.  For each staining process completed, half of the sections were 
stained using the DeadEnd Colorimetric TUNEL (Terminal deoxynucleotidyl transferase 
(TdT)-mediated deoxyuridine triphosphate nick-end labeling) System (Promega Corp., 
Madison, WI) to identify cellular DNA fragmentation that is characteristic of osteocyte 
apoptosis. The other half of the sections were stained with a created 2.0% methyl green 
solution that reveals non-apoptotic nuclei within each cross section. The methyl green 
solution was created by first mixing 2.72 grams of sodium acetate into 200 ml of distilled 
water, then adjusting the pH of the mixture to 4.2 using glacial acetic acid, and finally 
dissolving 4.0 g methyl green (Aldrich Chemical Co., St. Louis, MO)  into the resulting 
mixture. Microtomed sections were split between two stains to ensure that both viable 
and apoptotic osteocytes would be clearly visible throughout the counting process. To 
ensure likeness between cross-sections, the sections used for the TUNEL staining were 
directly adjacent to the sections used for the methyl green staining and, thus, were 
approximately only seven to thirty microns apart relative to original tissue placement.  
2.4 TUNEL staining and Osteocyte Apoptosis 
 
The first step in the TUNEL staining process is to deparaffinize sections by 
immersing the slides in xylene for 5 minutes. The tissue section were then rehydrated by 
graded ethanol washes: 8 minutes in 100%, 3 minutes in 95%, 3 minutes in 85%, 3 
minutes in 70%, and 3 minutes in 50% ethanol. The sections were then allowed to air dry 
for 20 minutes. After drying, the sections were rinsed for 5 minutes in phosphate buffered 
saline (PBS), refixed in Histochoice for 15 minutes and rinsed again in PBS for 10 
minutes.  To help permeabilize the tissue sections, 100 microliters of a 20µg/mL 
proteinase K solution was used to cover the tissue sections for 10 minutes at room 
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temperature.  After another PBS rinse, Histochoice refixing and second PBS rinse, 100 
microliters of equilibration buffer was placed on each slide to cover the sections for 10 
minutes.  A rTdT reaction mix was created by mixing 98 parts equilibration buffer with 1 
part biotinylated nucleotide mix and 1 part rTdT enzyme. After gently blotting away the 
previously equilibrated areas with tissue paper, 100 microliters of the rTdT reaction mix 
was added to each slide and then covered with a plastic coverslip to evenly distribute the 
reagent.  The slides were then incubated for 1 hour in a humidifying chamber at 37˚C to 
allow the end-labeling reaction to occur.  Following incubation, coverslips were removed 
and the slides were immersed in a 2x sodium-chloride sodium-citrate (SSC) wash to 
terminate the reaction. Three subsequent 5 minute rinses in PBS were then performed to 
remove unincorporated biotinylated nucleotides.  A 0.3% hydrogen peroxide in PBS mix 
was created and slides were allowed to sit in the mixture for 5 minutes to block 
endogenous peroxidases. Again, the slides were rinsed three times in PBS for five 
minutes each. The streptavidin HRP solution was diluted with PBS and 100 microliters of 
the mixture was added to each slide and allowed to sit for 30 minutes.  After three PBS 
rinses, the DAB components (DAB substrate 20x buffer and DAB 20xchromagen) were 
mixed with deionized water and hydrogen peroxide 20x just before use. Once mixed, 100 
microliters of the DAB mixture were added to each slide and allowed to develop until 
there was a light brown background. Finally, slides were rinsed several times in 
deionized water, excess liquid was removed and then the slides were mounted with 
Permount (Thermo Fischer Scientific).   
To perform the methyl green stain, sections were deparaffinized by immersing the 
slides in xylene for 5 minutes. The tissue sections were rehydrated by graded ethanol 
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washes: 8 minutes in 100%, 3 minutes in 95%, 3 minutes in 85%, 3 minutes in 70%, and 
3 minutes in 50% ethanol. The sections were then allowed to air dry for 20 minutes. After 
drying, the sections were rinsed in deionized water for 5 minutes, allowed to sit in the 2% 
methyl green solution (Aldrich Chemical Co., St. Louis, MO) for 30 seconds, and then 
rinsed again in distilled water. Excess liquid was removed and then the slides were 
mounted with Permount (Thermo Fischer Scientific). 
2.5 Image Capture, Processing, and Analysis 
 
To quantify osteocyte apoptosis and perform subsequent analyses, slides were 
observed under full-spectrum white light using a BX41 polarizing light microscope 
(Olympus Optical Co., Ltd., Center Valley, PA) at 40x magnification.  Images were 
captured using a Retiga EXi color camera (QImaging, Surrey, BC, Canada) and the Q 
Capture Pro imaging program (QImaging). After capturing all of the necessary images, 
Adobe Photoshop was used to combine all of the images taken from a specific cross-
section into a single image so that there was only one image for each cross section. Three 
cross sections of each stain, TUNEL and methyl green, were taken from each region, 
distal, midshaft and proximal, within the right and left tibias of all 9 subjects amounting 
to a grand total of 324 cross sections captured and created. A Ronchi ruler with known 
lines at a size of 150 lines per mm was used to calibrate the images at 40x magnification.  
Image analysis was performed using Image J (Wayne Rashband(NIH)) where images 
were calibrated with the Ronchi ruler, yielding total field dimensions of 0.23 mm by 0.17 
mm.  
Regarding analysis, the area for each bone cross-section and the quadrants therein 
contained, were calculated using the freehand selection tool within Image J. Two types of 
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osteocytes were counted for each stain. For the TUNEL stain, osteocytes in lacunae with 
their nuclei stained brown (Figure 11) were counted as apoptotic osteocytes. For the 
methyl green stain, osteocytes in lacunae with their nuclei stained blue (Figure 12) were 
counted as viable osteocytes.  
 
Figure 11.  TUNEL stained image showing stained osteocytes and empty lacunae.
 
Figure 12.  Methyl green stained image showing stained osteocytes and empty 
lacunae. 
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The total number of cells in each cross-section were counted in each anatomic 
quadrant (Cranial, Lateral, Caudal, Medial) and in each region (Proximal, Midshaft, 
Distal) along the tibia for all subjects (Figure 13). To ensure that only cells in-plane were 
counted, stained cells were only counted if they had a clearly defined lacunar wall. The 
amount of apoptotic and viable osteocytes present in each subject was expressed by 
calculating four different terms: the apoptotic osteocyte density (number of TUNEL 
stained cells per cross-sectional area), percent apoptotic osteocytes (number of TUNEL 
stained cells as a percent of the total cells counted in the cross section), viable osteocyte 
density (number of methyl green stained cells per cross-sectional area) and percent viable 
osteocytes (number of methyl green stained cells as a percent of the total cells counted in 
the cross section). 
 
Figure 13.  An example of what cross-sectional views across 3 regions of murine 
tibia look like stacked on top of each other, with samples on the left side(A) being 
TUNEL stained cross-sections, and samples directly to the right (B) being methyl 
green stained cross-sections (Cr=cranial, Ca=caudal, M=medial, L=lateral).  To the 
right of the cross-sections is an image of a tibia and fibula divided regionally to show 
the corresponding regions in which each cross-section sample was taken from.   
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2.6 Statistical Analysis 
 For this study, the statistical software Minitab 16 (Minitab) was used to analyze 
and compare all data collected using general linear models (GLM, ANOVA); pairwise 
comparisons were made using the Tukey method. Firstly, the four groups of tibias, 2 
week loaded left tibias, 2 week control right tibias, 5 week loaded left tibias and 5 week 
control right tibias, were analyzed individually to see if there were any statistically 
significant differences to be seen within each group independent of the others. Next, the 
groups of tibias were compared between each other. Comparisons were made between 
the 2 week loaded and 2 week control samples, the 5 week loaded and 5 week control 
samples, the 2 week loaded and 5 week loaded samples, and the 2 week control and 5 
week control samples.  For all data analyzed, differences in apoptotic osteocyte density, 
percentage of apoptotic osteocytes, viable osteocyte density and percentage of viable 
osteocytes were determined. These four variables were analyzed in each quadrant 
(Cranial, Lateral, Caudal, Medial), region (Proximal, Midshaft, Distal), and combination 
of both. Data was considered to be statistically significant if its related p-value was less 
than 0.05. 
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3. RESULTS 
3.1 Individual statistics for left tibias loaded for 2 weeks 
 
 Below are the statistics for all of the 2 week loaded left tibias, including a 
summary, analysis by quadrant, analysis by region and combinations of the latter two. 
For each statistical analysis, apoptotic osteocyte density, percentage of apoptotic 
osteocytes, viable osteocyte density and percentage of viable osteocytes were the 
variables considered. Mean values, standard deviations and relevant p-values are shown, 
with p-values less than 0.05 indicating statistically significant data.  
 A statistically significant lower percentage of apoptotic osteocytes can be seen in 
the lateral quadrants of 2 week loaded bones compared to the cranial and medial 
quadrants, when averaged across all regions. When specifically looking in the proximal 
region, the lateral quadrant had significantly lower percentage of apoptotic osteocytes 
than all other quadrants and a lower apoptotic osteocyte density compared to the medial 
quadrant. The caudal quandrant also showed a significantly lower percentage of apoptotic 
osteocytes when compared to the medial quadrant, within the proximal region. Only 
analyzing samples within the midshaft region showed that the percentage of apoptotic 
osteocytes within the lateral quadrant was lower than the medial quadrant. Looking 
within just the distal region showed that the percentage of viable osteocytes was 
significantly higher in the cranial quadrant compared to the lateral quadrant. No 
statistically significant differences between regions were seen when averaged across all 
quadrants. The only regional difference seen for 2 week loaded subjects, when looking 
only at data from medial quadrants, was that the distal region had a significantly less 
percentage of apoptotic osteocytes compared to the proximal region. 
29 
 
Table 1.  Apoptotic osteocyte density, viable osteocyte density, percentage of 
apoptotic osteocytes, and percentage of viable osteocytes for left tibias in all subjects 
that were loaded for 2 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Mean 
SUBJECT APOPTOTIC 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
APOPTOTIC 
OSTEOCYTES 
(%) 
VIABLE 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
VIABLE 
OSTEOCYTES 
(%) 
2WL1 84.274 31.6416 166.157 41.8833 
2WL2 129.092 38.7803 268.705 54.2325 
2WL3 162.850 41.2053 232.974 48.2845 
Overall 125.4(39.4) 37.21(4.97) 222.6(52.1) 48.13(6.18) 
 
Table 2.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
left tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
  
2 Week Loaded Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 150.1(38.4) 42.03(6.40) 258.3(63.3) 53.54(7.96) 
Lateral(L) 88.8(40.7) 26.62(5.80) 139.82(12.08) 33.41(1.79) 
Caudal(Cd) 112.1(46.8) 33.89(7.47) 211.4(52.1) 45.61(6.39) 
Medial(M) 146.1(34.6) 43.42(1.92) 244.7(109.0) 51.73(11.52) 
Cr-L .3162 .0461 .2252 .0514 
Cr-Cd .6711 .3726 .8340 .6129 
Cr-M .9993 .9905 .9945 .9912 
L-Cd .8915 .4611 .5984 .2896 
L-M .3662 .0306 .3087 .0770 
Cd-M .7374 .2581 .9303 .7704 
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Table 3.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 139.26(26.7) 42.49(4.23) 248.18(118.0) 54.36(14.24) 
Lateral(L) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
Caudal(Cd) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
Medial(M) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
Cr-L .2001 .0043 .2029 .2231 
Cr-Cd .9105 .4105 .7387 .8878 
Cr-M .5818 .1630 .8068 1.000 
L-Cd .4526 .0368 .6598 .5264 
L-M .0321 .0003 .5865 .2110 
Cd-M .2757 .0166 .9991 .8708 
 
Table 4.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
Lateral(L) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
Caudal(Cd) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.80) 
Medial(M) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
Cr-L .2238 .0534 .5296 .1737 
Cr-Cd .5184 .4498 .9602 .7419 
Cr-M .9939 .9997 .9958 .9908 
L-Cd .8946 .4319 .7950 .5924 
L-M .3102 .0472 .4164 .2561 
Cd-M .6580 .4072 .8914 .8817 
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Table 5.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
Lateral(L) 120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
Caudal(Cd) 112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
Medial(M) 102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
Cr-L .9479 .5801 .3484 .0193 
Cr-Cd .8747 .6247 .9139 .4190 
Cr-M .7456 .9105 .9994 .8548 
L-Cd .9963 .9998 .6813 .1853 
L-M .9615 .9099 .3999 .0582 
Cd-M .9929 .9360 .9492 .8402 
 
Table 6.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
left tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  123.53(42.6) 37.06(8.04) 262.57(50.0) 51.66(3.72) 
Midshaft(MS) 129.12(48.0) 36.67(2.95) 206.56(90.3) 44.08(9.63) 
Proximal(P) 123.56(29.8) 37.90(4.46) 198.71(65.2) 48.65(9.80) 
D-MS .9847 .9959 .6185 .5325 
D-P 1.000 .9812 .5431 .8968 
MS-P .9848 .9603 .9898 .7827 
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Table 7.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Cranial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
Midshaft(MS) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
Proximal(P) 139.26(26.7) 42.49(4.23) 248.18(118.) 54.36(14.24) 
D-MS .7290 .9192 .7210 .6704 
D-P .9978 .9961 .8142 .9551 
MS-P .6933 .9489 .9841 .8294 
 
Table 8.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Lateral Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
Midshaft(MS) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
Proximal(P) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
D-MS .4977 .6866 .1548 .2875 
D-P .5203 .4293 .1765 .4048 
MS-P .9990 .8829 .9942 .9544 
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Table 9.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Caudal Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
Midshaft(MS) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.8) 
Proximal(P) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
D-MS .9763 .9913 .5540 .3697 
D-P .9835 .8535 .4868 .8532 
MS-P .9232 .9098 .9911 .6475 
 
 
Table 10.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2 
weeks.  Standard deviations in parentheses. 
 
2 Week Loaded Medial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
Midshaft(MS) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
Proximal(P) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
D-MS .3400 .6984 .9590 .8434 
D-P .1704 .0361 .6540 .9921 
MS-P .8455 .1015 .8078 .7812 
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3.2 Individual statistics for right tibias used as 2 week controls 
 
 Below are the statistics for all of the 2 week unloaded right tibias used as controls, 
including a summary, analysis by quadrant, analysis by region and combinations of the 
latter two. For each statistical analysis, apoptotic osteocyte density, percentage of 
apoptotic osteocytes, viable osteocyte density and percentage of viable osteocytes were 
the variables considered. Mean values, standard deviations and relevant p-values are 
shown, with p-values less than 0.05 indicating statistically significant data.  
 For 2 week unloaded tibias, the percentage of apoptotic and viable osteocytes 
within the lateral quadrants were significantly lower than the medial quadrants, when 
averaged across all regions. The caudal quadrants showed a lower percentage of 
apoptotic osteocytes compared to the medial quadrants when averaged across all regions 
as well. When analyzing only within the proximal region, the lateral quadrant showed a 
significantly lower percentage of apoptotic osteocytes compared to all other quadrants. 
The caudal quadrant showed a lower percentage of apoptotic osteocytes as well when 
compared to the cranial and medial quadrants. The apoptotic osteocyte density of the 
lateral and the caudal quadrants were both significantly lower than that of the medial 
quadrant. When looking at data only within the midshaft region, the percentage of viable 
osteocytes was significantly lower in the lateral quadrant when compared to the cranial 
and medial while the caudal quadrant was only lower than the medial. No statistically 
significant differences were seen between regions when they were averaged across all 
quadrants; the percentage of apoptotic osteocytes in the proximal region was lower than 
that in the distal region, when solely looking at lateral quadrants. 
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Table 11.  Apoptotic osteocyte density, viable osteocyte density, percentage of 
apoptotic osteocytes, and percentage of viable osteocytes for right tibias used as 
controls in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Control Mean 
SUBJECT APOPTOTIC 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
APOPTOTIC 
OSTEOCYTES 
(%) 
VIABLE 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
VIABLE 
OSTEOCYTES 
(%) 
2WR1 86.712 30.2028 234.962 50.6915 
2WR2 128.724 35.1610 309.972 58.2828 
2WR3 154.713 34.8880 322.758 56.7443 
Overall 123.4(34.3) 33.42(2.79) 289.2(47.4) 55.24(4.01) 
 
 
Table 12.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
right tibias used as controls in all subjects that were loaded for 2 weeks.  Standard 
deviations in parentheses. 
 
2 Week Control Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 128.08(34.1) 36.20(2.08) 305.68(62.2) 59.06(6.36) 
Lateral(L) 107.65(31.1) 28.30(3.83) 242.22(34.7) 46.37(1.55) 
Caudal(Cd) 112.28(33.9) 30.21(2.91) 277.54(52.9) 52.05(5.01) 
Medial(M) 167.96(40.6) 38.92(4.06) 344.32(35.6) 61.03(6.19) 
Cr-L .8894 .0745 .4175 .0651 
Cr-Cd .9436 .1992 .8861 .3992 
Cr-M .5376 .7507 .7592 .9637 
L-Cd .9984 .8917 .8030 .5598 
L-M .2305 .0184 .1144 .0337 
Cd-M .2843 .0488 .3782 .2214 
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Table 13.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks. Standard deviations in parentheses. 
 
2 Week Control Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
Lateral(L) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
Caudal(Cd) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
Medial(M) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
Cr-L .0552 .0004 .1405 .0708 
Cr-Cd .3351 .0314 .6050 .3809 
Cr-M .0928 .8879 1.000 .9846 
L-Cd .5757 .0200 .6440 .6151 
L-M .0016 .0002 .1461 .1156 
Cd-M .0079 .0119 .6208 .5561 
 
Table 14.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks. Standard deviations in parentheses. 
 
2 Week Control Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
Lateral(L) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
Caudal(Cd) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
Medial(M) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
Cr-L .9683 .4294 .8375 .0170 
Cr-Cd .9681 .5213 .9873 .1489 
Cr-M .7637 .9919 .2496 .6913 
L-Cd 1.000 .9978 .9548 .4494 
L-M .5173 .3079 .0792 .0041 
Cd-M .5170 .3831 .1613 .0312 
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Table 15.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks. Standard deviations in parentheses. 
 
2 Week Control Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
Lateral(L) 143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
Caudal(Cd) 133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
Medial(M) 162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
Cr-L .9894 .9745 .9829 .9655 
Cr-Cd .9999 .9166 1.000 .9999 
Cr-M .8505 .5965 .9940 .9414 
L-Cd .9946 .7255 .9887 .9781 
L-M .9570 .8200 .9995 .7421 
Cd-M .8777 .2915 .9968 .9203 
 
Table 16.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
right tibias used as controls in all subjects that were loaded for 2 weeks.  Standard 
deviations in parentheses. 
 
2 Week Control Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  138.65(49.4) 34.19(4.82) 305.10(61.4) 57.41(8.62) 
Midshaft(MS) 127.87(47.9) 33.16(5.05) 290.88(76.4) 54.39(2.97) 
Proximal(P) 103.63(11.37) 32.90(1.36) 271.71(21.5) 53.92(1.24) 
D-MS .9430 .9495 .9518 .7749 
D-P .5674 .9229 .7691 .7153 
MS-P .7518 .9968 .9147 .9937 
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Table 17.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks.  Standard deviations in parentheses. 
 
2 Week Control Cranial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
Midshaft(MS) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
Proximal(P) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
D-MS .9973 .7728 .9510 .9683 
D-P .9403 .5490 .9991 .8579 
MS-P .9146 .9169 .9375 .9545 
 
Table 18.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks.  Standard deviations in parentheses. 
 
2 Week Control Lateral Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
Midshaft(MS) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
Proximal(P) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
D-MS .6152 .2969 .4224 .2440 
D-P .0676 .0338 .1145 .1326 
MS-P .2339 .2667 .5691 .8818 
 
 
  
39 
 
Table 19.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks.  Standard deviations in parentheses. 
 
2 Week Control Caudal Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
Midshaft(MS) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
Proximal(P) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
D-MS .8683 .8293 .7376 .3233 
D-P .4355 .8806 .5404 .2986 
MS-P .7120 .9938 .9348 .9976 
 
 
Table 20.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 2 weeks.  Standard deviations in parentheses. 
 
2 Week Control Medial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
Midshaft(MS) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
Proximal(P) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
D-MS .9663 .9532 .1571 .9698 
D-P .9865 .9929 .9671 .9180 
MS-P .9953 .9127 .2147 .8080 
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3.3 Individual statistics for left tibias loaded for 5 weeks 
 
Below are the statistics for all of the 5 week loaded left tibias, including a 
summary, analysis by quadrant, analysis by region and combinations of the latter two. 
For each statistical analysis, apoptotic osteocyte density, percentage of apoptotic 
osteocytes, viable osteocyte density and percentage of viable osteocytes were the 
variables considered. Mean values, standard deviations and relevant p-values are shown, 
with p-values less than 0.05 indicating statistically significant data. 
 For 5 week loaded data averaged across all regions, the lateral quadrants showed 
significantly lower percentages of viable osteocytes when compared to all other 
quadrants and significantly lower density of viable osteocytes when compared to the 
cranial quadrants. When looking at samples only taken from proximal regions, the lateral 
quadrants showed significantly lower percentages and densities of viable osteocytes 
compared to all other quadrants. These proximal lateral quadrants also showed lower 
percentages and densities of apoptotic osteocytes compared to the medial quadrants in the 
same region. Only analyzing samples within the midshaft region showed that there were 
significantly less percentages of viable osteocytes in the lateral quadrants compared to the 
medial quadrants. Looking only at samples within the distal region showed that there 
were significantly lower percentages of viable osteocytes in the lateral quadrants 
compared to the cranial and medial quadrants.  
 When averaged across all quadrants, midshaft samples showed higher viable 
osteocyte densities than the distal and proximal regions. When looking only within the 
cranial quadrant, distal samples showed significantly less viable osteocyte densities than 
midshaft samples. Isolating lateral quadrant samples showed significantly higher 
densities of apoptotic osteocytes, percentages of apoptotic osteocytes and densities of 
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viable osteocytes in the midshaft compared to in the proximal region. Regional data 
solely from the caudal quadrant showed significantly higher apoptotic osteocyte densities 
in the midshaft compared to the proximal regions and significantly higher densities of 
viable osteocytes in the midshaft compared to both the distal and proximal regions.    
 
Table 21.  Apoptotic osteocyte density, viable osteocyte density, percentage of 
apoptotic osteocytes, and percentage of viable osteocytes for left tibias in all subjects 
that were loaded for 5 weeks. Standard deviations in parentheses. 
 
5 Week Loaded Mean 
SUBJECT APOPTOTIC 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
APOPTOTIC 
OSTEOCYTES 
(%) 
VIABLE 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
VIABLE 
OSTEOCYTES 
(%) 
5WL1 254.335 58.0080 288.214 61.8257 
5WL2 237.385 60.0225 321.218 64.8525 
5WL3 276.643 61.7180 338.626 64.3634 
5WL4 236.360 62.2560 296.044 63.0723 
5WL5 253.074 58.8612 374.637 63.5759 
5WL6 168.333 54.4083 339.155 66.5362 
Overall 237.7(37.0) 59.21(2.86) 326.3(52.1) 64.04(1.62) 
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Table 22.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
left tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 236.27(37.8) 59.90(3.83) 348.55(35.4) 67.22(1.50) 
Lateral(L) 232.46(56.8) 58.00(3.47) 272.02(63.1) 54.68(5.81) 
Caudal(Cd) 239.50(38.3) 58.40(3.39) 330.77(23.34) 63.75(2.72) 
Medial(M) 256.88(59.1) 60.31(2.46) 333.68(42.3) 67.36(1.34) 
Cr-L .9991 .7587 .0298 .0000 
Cr-Cd .9995 .8635 .8927 .3089 
Cr-M .8847 .9964 .9333 .9999 
L-Cd .9944 .9967 .1224 .0008 
L-M .8238 .6336 .0986 .0000 
Cd-M .9264 .7555 .9994 .2780 
 
Table 23.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
Lateral(L) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
Caudal(Cd) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
Medial(M) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
Cr-L .2927 .1043 .0025 .0006 
Cr-Cd .9691 .9089 .9012 .9600 
Cr-M .1845 .3423 .8770 .9999 
L-Cd .5296 .3207 .0116 .0018 
L-M .0042 .0026 .0133 .0005 
Cd-M .0811 .1135 .999 .9472 
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Table 24.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
Lateral(L) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
Caudal(Cd) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
Medial(M) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
Cr-L .9698 .9013 .8037 .0527 
Cr-Cd .9162 .9999 .9968 .6626 
Cr-M .9206 .9477 .9981 .9717 
L-Cd .9971 .8732 .8970 .3901 
L-M .9976 .6172 .8842 .0211 
Cd-M 1.000 .9644 1.000 .4080 
 
Table 25.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
Lateral(L) 245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
Caudal(Cd) 220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
Medial(M) 205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
Cr-L .9682 .9864 .2240 .0006 
Cr-Cd .9873 .9107 .8454 .1075 
Cr-M .8594 .9719 .9652 .9170 
L-Cd .8614 .9880 .6492 .1162 
L-M .6093 .9997 .4425 .0027 
Cd-M .9673 .9958 .9849 .3175 
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Table 26.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
left tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  225.88(41.0) 57.08(5.41) 302.42(19.36) 64.32(2.00) 
Midshaft(MS) 272.75(68.7) 62.78(3.77) 377.70(52.9) 64.97(3.61) 
Proximal(P) 214.44(24.9) 57.78(2.74) 298.83(49.0) 62.82(3.85) 
D-MS .2459 .0727 .0219 .9363 
D-P .9122 .9534 .9886 .7102 
MS-P .1263 .1230 .0165 .5032 
 
Table 27.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Cranial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
Midshaft(MS) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
Proximal(P) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
D-MS .6836 .4022 .0448 .9490 
D-P .9514 .9989 .9239 .5878 
MS-P .5036 .4259 .0905 .7718 
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Table 28.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Lateral Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
Midshaft(MS) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
Proximal(P) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
D-MS .6811 .1106 .2405 .9956 
D-P .1862 .3396 .3028 .0665 
MS-P .0411 .0067 .0147 .0783 
 
 
Table 29.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Caudal Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
Midshaft(MS) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
Proximal(P) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
D-MS .0781 .1004 .0078 .9919 
D-P .9322 .9341 .9120 .9213 
MS-P .0400 .1829 .0177 .9620 
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Table 30.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5 
weeks.  Standard deviations in parentheses. 
 
5 Week Loaded Medial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
Midshaft(MS) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
Proximal(P) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
D-MS .2508 .4578 .2651 .6743 
D-P .3338 .1895 .9994 1.000 
MS-P .9788 .8119 .2522 .6719 
 
 
3.4 Individual statistics for right tibias used as 5 week controls 
 
Below are the statistics for all of the 5 week unloaded right tibias used as controls, 
including a summary, analysis by quadrant, analysis by region and combinations of the 
latter two. For each statistical analysis, apoptotic osteocyte density, percentage of 
apoptotic osteocytes, viable osteocyte density and percentage of viable osteocytes were 
the variables considered. Mean values, standard deviations and relevant p-values are 
shown, with p-values less than 0.05 indicating statistically significant data.  
 No statistically significant data differences were seen between quadrants, when 
averaged across all regions, or between regions, when averaged across all quadrants. The 
only statistically significant difference seen showed higher viable osteocyte densities in 
midshafts compared to samples in the proximal region, when analyzing within the medial 
quadrant only. 
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Table 31.  Apoptotic osteocyte density, viable osteocyte density, percentage of 
apoptotic osteocytes, and percentage of viable osteocytes for right tibias used as 
controls in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Control Mean 
SUBJECT APOPTOTIC 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
APOPTOTIC 
OSTEOCYTES 
(%) 
VIABLE 
OSTEOCYTE 
DENSITY 
(#/mm
2
) 
PERCENTAGE 
VIABLE 
OSTEOCYTES 
(%) 
5WR1 132.827 41.1027 351.098 60.0203 
5WR2 148.814 35.8902 399.276 57.1673 
5WR3 125.390 32.8866 392.888 60.4484 
5WR4 186.986 46.9419 300.056 68.5789 
5WR5 169.658 43.1078 271.562 72.1905 
5WR6 126.423 33.8280 389.805 64.6432 
Overall 148.3(25.3) 38.96(5.62) 350.8(53.8) 63.84(5.72) 
 
 Table 32.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
right tibias used as controls in all subjects that were loaded for 5 weeks.  Standard 
deviations in parentheses. 
 
5 Week Control Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 151.11(17.04) 41.24(4.74) 358.88(83.2) 66.72(3.11) 
Lateral(L) 154.51(36.2) 36.82(6.58) 319.53(27.5) 57.41(10.05) 
Caudal(Cd) 141.49(28.4) 37.35(6.70) 368.86(59.6) 64.33(7.15) 
Medial(M) 154.90(45.1) 38.35(6.07) 336.28(58.0) 64.63(6.75) 
Cr-L .9980 .5964 .6770 .1466 
Cr-Cd .9581 .6867 .9916 .9384 
Cr-M .9972 .8415 .9151 .9575 
L-Cd .9046 .9987 .5054 .3673 
L-M 1.000 .9715 .9626 .3316 
Cd-M .8971 .9916 .7872 .9999 
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Table 33.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks. Standard deviations in parentheses. 
 
5 Week Control Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
Lateral(L) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
Caudal(Cd) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
Medial(M) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
Cr-L .9261 .4532 .7152 .2644 
Cr-Cd .8758 .8497 .8352 .9812 
Cr-M .9272 .8450 .7583 .8022 
L-Cd .9991 .8972 .2587 .1402 
L-M .6179 .9011 .9998 .7607 
Cd-M .5368 1.000 .2908 .5841 
 
Table 34.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks. Standard deviations in parentheses. 
 
5 Week Control Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
Lateral(L) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
Caudal(Cd) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
Medial(M) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
Cr-L .6421 .9920 .8794 .2397 
Cr-Cd .9779 .9687 .9965 .9317 
Cr-M .9758 .8557 .9973 .9675 
L-Cd .4088 .9982 .9510 .5416 
L-M .4018 .9546 .9466 .4596 
Cd-M 1.000 .9855 1.000 .9990 
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Table 35.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks. Standard deviations in parentheses. 
 
5 Week Control Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
Lateral(L) 136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
Caudal(Cd) 136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
Medial(M) 144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
Cr-L .9999 .7686 .9267 .2565 
Cr-Cd 1.000 .7008 .9995 .5414 
Cr-M .9975 .9920 .9925 .9994 
L-Cd 1.000 .9994 .8873 .9443 
L-M .9941 .9005 .9864 .2113 
Cd-M .9953 .8503 .9802 .4710 
 
Table 36.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for 
right tibias used as controls in all subjects that were loaded for 5 weeks.  Standard 
deviations in parentheses. 
 
5 Week Control Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  139.09(45.8) 37.63(8.96) 350.68(71.9) 64.41(7.51) 
Midshaft(MS) 163.32(22.7) 39.67(7.46) 394.35(83.1) 64.55(5.68) 
Proximal(P) 142.64(22.93) 39.58(5.51) 307.31(69.6) 62.56(6.33) 
D-MS .4179 .8836 .5838 .9993 
D-P .9803 .8937 .5881 .8774 
MS-P .5242 .9997 .1447 .8601 
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Table 37.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks.  Standard deviations in parentheses. 
 
5 Week Control Cranial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
Midshaft(MS) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
Proximal(P) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
D-MS .2685 .9999 .6354 .9015 
D-P .7469 .9594 .7568 .3785 
MS-P .6585 .9637 .2602 .6249 
 
 
Table 38.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks.  Standard deviations in parentheses. 
 
5 Week Control Lateral Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
Midshaft(MS) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
Proximal(P) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
D-MS .1799 .6194 .6487 .9965 
D-P .9993 .9985 .3140 .7243 
MS-P .1697 .6507 .0709 .7706 
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Table 39.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks.  Standard deviations in parentheses. 
 
5 Week Control Caudal Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
Midshaft(MS) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
Proximal(P) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
D-MS .7163 .6623 .7539 .8523 
D-P .9760 .7002 .9821 .6357 
MS-P .5898 .9978 .6460 .9240 
 
 
Table 40.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes for right tibias used as controls in all subjects that 
were loaded for 5 weeks.  Standard deviations in parentheses. 
 
5 Week Control Medial Region 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Distal(D)  144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
Midshaft(MS) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
Proximal(P) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
D-MS .9457 .9361 .4739 .7043 
D-P .8122 .9910 .2667 .1510 
MS-P .9518 .9741 .0328 .4856 
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3.5 Comparison Between 2 Week Loaded Left Tibias and Unloaded Right Tibia 
Controls 
 
Below are the statistics for all of the 2 week loaded left tibias compared against 
all of the 2 week unloaded right tibias used as controls, including a summary, analysis by 
quadrant, analysis by region and combinations of the latter two. For each statistical 
analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable osteocyte 
density and percentage of viable osteocytes were the variables considered. Mean values, 
standard deviations and relevant p-values are shown, with p-values less than 0.05 
indicating statistically significant data. 
 When comparing the 2 week loaded data against the unloaded data, only one 
statistically significant difference was found; the percentage of apoptotic osteocytes in 
the medial quadrant of the proximal region for the 2 week loaded bones was significantly 
higher than in the 2 week unloaded bones. 
 
  
53 
 
Table 41.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between loaded left tibias and control right tibias in all subjects that were loaded for 
2 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/2 Week Control Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 150.1(38.4) 42.03(6.40) 258.3(63.3) 53.54(7.96) 
2WL_Lateral(L2WL) 88.8(40.7) 26.62(5.80) 139.82(12.08) 33.41(1.79) 
2WL_Caudal(Cd2WL) 112.1(46.8) 33.89(7.47) 211.4(52.1) 45.61(6.39) 
2WL_Medial(M2WL) 146.1(34.6) 43.42(1.92) 244.7(109.0) 51.73(11.52) 
2WR_Cranial(Cr2WR) 128.08(34.1) 36.20(2.08) 305.68(62.2) 59.06(6.36) 
2WR_Lateral(L2WR) 107.65(31.1) 28.30(3.83) 242.22(34.7) 46.37(1.55) 
2WR_Caudal(Cd2WR) 112.28(33.9) 30.21(2.91) 277.54(52.9) 52.05(5.01) 
2WR_Medial(M2WR) 167.96(40.6) 38.92(4.06) 344.32(35.6) 61.03(6.19) 
Cr2WL-Cr2wR .9953 .7897 .9709 .9631 
L2WL-L2WR .9982 .9998 .4406 .2993 
Cd2WL-Cd2WR 1.000 .9748 .8570 .9207 
M2WL-M2WR .9955 .9298 .4732 .6691 
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Table 42.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 139.26(26.7) 42.49(4.23) 248.18(118.0) 54.36(14.24) 
2WL_Lateral(L2WL) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
2WL_Caudal(Cd2WL) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
2WL_Medial(M2WL) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
2WR_Cranial(Cr2WR) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
2WR_Lateral(L2WR) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
2WR_Caudal(Cd2WR) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
2WR_Medial(M2WR) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
Cr2WL-Cr2wR .9906 .8489 .9211 .9955 
L2WL-L2WR .9999 .9995 .8097 .9400 
Cd2WL-Cd2WR .8788 .5610 .9121 1.000 
M2WL-M2WR .9999 .0285 .4167 .9999 
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Table 43.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
2WL_Lateral(L2WL) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
2WL_Caudal(Cd2WL) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.80) 
2WL_Medial(M2WL) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
2WR_Cranial(Cr2WR) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
2WR_Lateral(L2WR) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
2WR_Caudal(Cd2WR) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
2WR_Medial(M2WR) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
Cr2WL-Cr2wR .9875 .9888 .9958 .9603 
L2WL-L2WR .9638 .9991 .7168 .4041 
Cd2WL-Cd2WR 1.000 .9906 .9682 .8598 
M2WL-M2WR 1.000 .9980 .4507 .3244 
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Table 44.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
2WL_Lateral(L2WL) 120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
2WL_Caudal(Cd2WL) 112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
2WL_Medial(M2WL) 102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
2WR_Cranial(Cr2WR) 131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
2WR_Lateral(L2WR) 143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
2WR_Caudal(Cd2WR) 133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
2WR_Medial(M2WR) 162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
Cr2WL-Cr2wR 1.000 .8716 .9999 1.000 
L2WL-L2WR .9988 .9984 .5799 .3569 
Cd2WL-Cd2WR .9992 1.000 .9635 .9285 
M2WL-M2WR .7710 1.000 1.000 .8615 
 
Table 45.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between loaded left tibias and control right tibias in all subjects that were loaded for 
2 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/2 Week Control Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptoti
c 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 123.53(42.6) 37.06(8.04) 262.57(50.0) 51.66(3.72) 
2WL_Midshaft(MS2WL) 129.12(48.0) 36.67(2.95) 206.56(90.3) 44.08(9.63) 
2WL_Proximal(P2WL) 123.56(29.8) 37.90(4.46) 198.71(65.2) 48.65(9.80) 
2WR_Distal(D2WR) 138.65(49.4) 34.19(4.82) 305.10(61.4) 57.41(8.62) 
2WR_Midshaft(MS2WR) 127.87(47.9) 33.16(5.05) 290.88(76.4) 54.39(2.97) 
2WR_Proximal(P2WR) 103.63(11.37) 32.90(1.36) 271.71(21.5) 53.92(1.24) 
D2WL-D2wR .9969 .9761 .9607 .9038 
MS2WL-MS2WR 1.000 .9450 .6130 .4870 
P2WL-P2WR .9889 .8047 .7344 .9301 
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Table 46.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Cranial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
2WL_Midshaft(MS2WL) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
2WL_Proximal(P2WL) 139.26(26.7) 42.49(4.23) 248.18(118.) 54.36(14.24) 
2WR_Distal(D2WR) 131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
2WR_Midshaft(MS2WR) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
2WR_Proximal(P2WR) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
D2WL-D2wR .9996 .5112 .9995 1.000 
MS2WL-MS2WR .8983 .9612 .9597 .7873 
P2WL-P2WR .9920 .9385 .9157 .9438 
 
Table 47.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Lateral Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
2WL_Midshaft(MS2WL) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
2WL_Proximal(P2WL) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
2WR_Distal(D2WR) 143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
2WR_Midshaft(MS2WR) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
2WR_Proximal(P2WR) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
D2WL-D2wR .9859 .9813 .2292 .3523 
MS2WL-MS2WR .8050 .9969 .0665 .2447 
P2WL-P2WR .9997 .9997 .3898 .6082 
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Table 48.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Caudal Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
2WL_Midshaft(MS2WL) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.8) 
2WL_Proximal(P2WL) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
2WR_Distal(D2WR) 133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
2WR_Midshaft(MS2WR) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
2WR_Proximal(P2WR) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
D2WL-D2wR .9926 1.000 .9192 .8206 
MS2WL-MS2WR .9995 .9731 .7104 .5759 
P2WL-P2WR .9526 .8407 .8096 .9934 
 
Table 49.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 2 weeks.  Standard deviations in 
parentheses. 
 
2 Week Loaded/2 Week Control Medial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
2WL_Midshaft(MS2WL) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
2WL_Proximal(P2WL) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
2WR_Distal(D2WR) 162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
2WR_Midshaft(MS2WR) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
2WR_Proximal(P2WR) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
D2WL-D2wR .5935 .9978 1.000 .9570 
MS2WL-MS2WR .9985 .9753 .3827 .5691 
P2WL-P2WR .9998 .1045 .6862 .9987 
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3.6 Comparison Between 5 Week Loaded Left Tibias and Unloaded Right Tibia 
Controls 
 
Below are the statistics for all of the 5 week loaded left tibias compared against 
all of the 5 week unloaded right tibias used as controls, including a summary, analysis by 
quadrant, analysis by region and combinations of the latter two. For each statistical 
analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable osteocyte 
density and percentage of viable osteocytes were the variables considered. Mean values, 
standard deviations and relevant p-values are shown, with p-values less than 0.05 
indicating statistically significant data. 
 When comparing the 5 week loaded data against the unloaded data, the 
percentage of apoptotic osteocytes, in each region, quadrant and combination of the two, 
were higher in 5 week loaded bones when compared against the 5 week unloaded bones 
from the same region and quadrant. No statistically significant differences in viable 
osteocyte density or percentage of viable osteocytes were seen between the 5 week 
loaded samples and the 5 week unloaded control samples. The density of apoptotic 
osteocytes in each quadrant, averaged across all regions, were significantly higher in the 
5 week loaded bones than their respective counterparts in the 5 week unloaded bones. 
The medial quadrants in proximal and midshaft samples, the caudal quadrants in midshaft 
samples and the lateral quadrants in distal samples showed significantly higher densities 
of apoptotic osteocytes in 5 week loaded bones compared to 5 week unload bones. The 
density of apoptotic osteocytes in the distal and midshaft regions, averaged across all 
quadrants, were higher in 5 week loaded bones when compared against the 5 week 
unloaded bones from the same region. The distal regions of cranial, lateral and caudal 
quadrants showed statistically significantly higher apoptotic osteocyte densities in 5 week 
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loaded samples compared to 5 week unloaded samples. The 5 week loaded midshaft 
regions in the cranial, caudal and medial quadrants of bone showed statistically 
significantly higher apoptotic osteocyte densities compared to 5 week unloaded samples.  
 
Table 50.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between loaded left tibias and control right tibias in all subjects that were loaded for 
5 weeks.  Standard deviations in parentheses. 
 
5 Week Loaded/5 Week Control Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptoti
c 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Cranial(Cr5WL) 236.27(37.8) 59.90(3.83) 348.55(35.4) 67.22(1.50) 
5WL_Lateral(L5WL) 232.46(56.8) 58.00(3.47) 272.02(63.1) 54.68(5.81) 
5WL_Caudal(Cd5WL) 239.50(38.3) 58.40(3.39) 330.77(23.34) 63.75(2.72) 
5WL_Medial(M5WL) 256.88(59.1) 60.31(2.46) 333.68(42.3) 67.36(1.34) 
5WR_Cranial(Cr5WR) 151.11(17.04) 41.24(4.74) 358.88(83.2) 66.72(3.11) 
5WR_Lateral(L5WR) 154.51(36.2) 36.82(6.58) 319.53(27.5) 57.41(10.05) 
5WR_Caudal(Cd5WR) 141.49(28.4) 37.35(6.70) 368.86(59.6) 64.33(7.15) 
5WR_Medial(M5WR) 154.90(45.1) 38.35(6.07) 336.28(58.0) 64.63(6.75) 
Cr5WL-Cr5WR 0.0221 0.0000 1.0000 1.0000 
L5WL-L5WR 0.0471 0.0000 0.7685 0.9896 
Cd5WL-Cd5WR 0.0051 0.0000 0.9102 1.0000 
M5WL-M5WR 0.0032 0.0000 1.0000 0.9895 
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Table 51.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Cranial(Cr5WL) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
5WL_Lateral(L5WL) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
5WL_Caudal(Cd5WL) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
5WL_Medial(M5WL) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
5WR_Cranial(Cr5WR) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
5WR_Lateral(L5WR) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
5WR_Caudal(Cd5WR) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
5WR_Medial(M5WR) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
Cr5WL-Cr5WR .1170 .0009 .9997 .9999 
L5WL-L5WR .7908 .0007 .6777 .7899 
Cd5WL-Cd5WR .0662 .0002 .9640 .9998 
M5WL-M5WR .0017 0.000 .9708 .8157 
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Table 52.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptoti
c 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Cranial(Cr5WL) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
5WL_Lateral(L5WL) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
5WL_Caudal(Cd5WL) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
5WL_Medial(M5WL) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
5WR_Cranial(Cr5WR) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
5WR_Lateral(L5WR) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
5WR_Caudal(Cd5WR) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
5WR_Medial(M5WR) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
Cr5WL-Cr5WR .2884 0.0000 1.0000 1.0000 
L5WL-L5WR .3575 0.0000 1.0000 1.0000 
Cd5WL-Cd5WR .0283 0.0000 1.0000 1.0000 
M5WL-M5WR .0290 0.0000 1.0000 .9804 
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Table 53.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Cranial(Cr5WL) 230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
5WL_Lateral(L5WL) 245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
5WL_Caudal(Cd5WL) 220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
5WL_Medial(M5WL) 205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
5WR_Cranial(Cr5WR) 138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
5WR_Lateral(L5WR) 136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
5WR_Caudal(Cd5WR) 136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
5WR_Medial(M5WR) 144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
Cr5WL-Cr5WR .0957 .0162 .9816 1.0000 
L5WL-L5WR .0272 .0014 .7369 1.0000 
Cd5WL-Cd5WR .1745 .0020 .7191 1.0000 
M5WL-M5WR .5345 .0171 .9813 .9976 
 
Table 54.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between loaded left tibias and control right tibias in all subjects that were loaded for 
5 weeks.  Standard deviations in parentheses. 
 
5 Week Loaded/5 Week Control Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Distal(D5WL) 225.88(41.0) 57.08(5.41) 302.42(19.36) 64.32(2.00) 
5WL_Midshaft(MS5WL) 272.75(68.7) 62.78(3.77) 377.70(52.9) 64.97(3.61) 
5WL_Proximal(P5WL) 214.44(24.9) 57.78(2.74) 298.83(49.0) 62.82(3.85) 
5WR_Distal(D5WR) 139.09(45.8) 37.63(8.96) 350.68(71.9) 64.41(7.51) 
5WR_Midshaft(MS5WR) 163.32(22.7) 39.67(7.46) 394.35(83.1) 64.55(5.68) 
5WR_Proximal(P5WR) 142.64(22.93) 39.58(5.51) 307.31(69.6) 62.56(6.33) 
D5WL-D5WR .0115 0.0001 .7468 1.0000 
MS5WL-MS5WR .0009 0.0000 .9968 1.0000 
P5WL-P5WR .0523 0.0002 .9999 1.0000 
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Table 55.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Cranial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Distal(D5WL) 230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
5WL_Midshaft(MS5WL) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
5WL_Proximal(P5WL) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
5WR_Distal(D5WR) 138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
5WR_Midshaft(MS5WR) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
5WR_Proximal(P5WR) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
D5WL-D5WR .0065 .0009 .9761 .9998 
MS5WL-MS5WR .0073 .0001 .9991 1.0000 
P5WL-P5WR .0542 .0021 .9983 .9581 
 
Table 56.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Lateral Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Distal(D5WL) 245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
5WL_Midshaft(MS5WL) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
5WL_Proximal(P5WL) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
5WR_Distal(D5WR) 136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
5WR_Midshaft(MS5WR) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
5WR_Proximal(P5WR) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
D5WL-D5WR .0367 .0001 .7686 1.0000 
MS5WL-MS5WR .1525 .0000 .9986 1.0000 
P5WL-P5WR .8669 .0024 .6565 .7815 
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Table 57.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Caudal Region  
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Distal(D5WL) 220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
5WL_Midshaft(MS5WL) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
5WL_Proximal(P5WL) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
5WR_Distal(D5WR) 136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
5WR_Midshaft(MS5WR) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
5WR_Proximal(P5WR) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
D5WL-D5WR .0354 .0001 .6649 .9995 
MS5WL-MS5WR .0003 .0000 .9992 .9999 
P5WL-P5WR .0565 .0008 .9041 .9959 
 
Table 58.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between loaded left tibias and control 
right tibias in all subjects that were loaded for 5 weeks.  Standard deviations in 
parentheses. 
 
5 Week Loaded/5 Week Control Medial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
5WL_Distal(D5WL) 205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
5WL_Midshaft(MS5WL) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
5WL_Proximal(P5WL) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
5WR_Distal(D5WR) 144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
5WR_Midshaft(MS5WR) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
5WR_Proximal(P5WR) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
D5WL-D5WR .6896 .0062 .9764 .9873 
MS5WL-MS5WR .0393 .0002 .9997 .9309 
P5WL-P5WR .1100 .0001 .9541 .4670 
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3.7 Comparison Between 2 Week Loaded Left Tibias and 5 Week Loaded Left 
Tibias 
 
Below are the statistics for all of the 2 week loaded left tibias compared against 
all of the 5 week loaded left tibias, including a summary, analysis by quadrant, analysis 
by region and combinations of the latter two. For each statistical analysis, apoptotic 
osteocyte density, percentage of apoptotic osteocytes, viable osteocyte density and 
percentage of viable osteocytes were the variables considered. Mean values, standard 
deviations and relevant p-values are shown, with p-values less than 0.05 indicating 
statistically significant data. 
 The lateral quadrants, isolated to each region individually and averaged across all 
regions; the caudal quadrants, isolated to the midshaft region and averaged across all 
regions; and the medial quadrants, averaged across all regions, showed significantly 
higher densities of apoptotic osteocytes in 5 week loaded bone compared to 2 week 
loaded samples. The midshaft regions, when isolated to lateral quadrants, caudal 
quadrants and an averaged across all quadrants, showed significantly higher densities of 
apoptotic osteocytes in 5 week loaded bones compared to 2 week loaded bones as well. 
The 5 week loaded quadrants, isolated to the proximal region, midshaft region and 
average across all regions, and 5 week loaded regions, isolated to the cranial quadrant, 
lateral quadrant, caudal quadrant and average across all quadrants, showed significantly 
higher percentages of apoptotic osteocytes compared to the respective quadrants or 
regions of the 2 week loaded samples. The lateral, caudal and medial quadrants, isolated 
to the distal region, and the distal and midshaft regions, both isolated to medial quadrant, 
also showed a significantly higher percentage of apoptotic osteocytes in the 5 week 
loaded samples compared to the 2 week load samples. Lateral quadrants, when averaged 
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across all regions and when isolated to the midshaft region, showed significantly higher 
densities of viable osteocytes in 5 week loaded bones compared to 2 week loaded bones. 
Midshaft regions, when isolated to cranial quadrants, lateral quadrants, caudal quadrants 
and averaged across all quadrants, and proximal regions, isolated to the caudal quadrant, 
showed significantly higher densities of viable osteocytes in 5 week loaded bones 
compared to 2 week loaded bones as well. The 5 week loaded quadrants, isolated to the 
distal region, midshaft region and averaged across all regions, and the 5 week loaded 
regions, averaged across all quadrants, showed a significantly higher percentage of viable 
osteocytes compared to the respective quadrants or regions in the 2 week loaded samples. 
The midshafts, when isolated by each individual quadrant, and the proximal regions, 
isolated to the caudal quadrant, also showed a significantly less percentage of viable 
osteocytes in the 2 week loaded samples compared to the 5 week samples. 
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Table 59.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between left tibias loaded for 2 weeks and left tibias loaded for 5 weeks.  Standard 
deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 150.1(38.4) 42.03(6.40) 258.3(63.3) 53.54(7.96) 
2WL_Lateral(L2WL) 88.8(40.7) 26.62(5.80) 139.82(12.08) 33.41(1.79) 
2WL_Caudal(Cd2WL) 112.1(46.8) 33.89(7.47) 211.4(52.1) 45.61(6.39) 
2WL_Medial(M2WL) 146.1(34.6) 43.42(1.92) 244.7(109.0) 51.73(11.52) 
5WL_Cranial(Cr5WL) 236.27(37.8) 59.90(3.83) 348.55(35.4) 67.22(1.50) 
5WL_Lateral(L5WL) 232.46(56.8) 58.00(3.47) 272.02(63.1) 54.68(5.81) 
5WL_Caudal(Cd5WL) 239.50(38.3) 58.40(3.39) 330.77(23.34) 63.75(2.72) 
5WL_Medial(M5WL) 256.88(59.1) 60.31(2.46) 333.68(42.3) 67.36(1.34) 
Cr2WL-Cr5WL .1950 .0001 .2539 .0126 
L2WL-L5WL .0036 .0000 .0230 .0001 
Cd2WL-Cd5WL .0125 .0000 .0518 .0005 
M2WL-M5WL .0416 .0001 .2685 .0031 
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Table 60.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 139.26(26.7) 42.49(4.23) 248.18(118.0) 54.36(14.24) 
2WL_Lateral(L2WL) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
2WL_Caudal(Cd2WL) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
2WL_Medial(M2WL) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
5WL_Cranial(Cr5WL) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
5WL_Lateral(L5WL) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
5WL_Caudal(Cd5WL) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
5WL_Medial(M5WL) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
Cr2WL-Cr5WL .1616 .0007 .5521 .6081 
L2WL-L5WL .0486 .0000 .5331 .2472 
Cd2WL-Cd5WL .0982 .0000 .1211 .1550 
M2WL-M5WL .0517 .0321 .1882 .6323 
 
  
70 
 
Table 61.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
2WL_Lateral(L2WL) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
2WL_Caudal(Cd2WL) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.80) 
2WL_Medial(M2WL) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
5WL_Cranial(Cr5WL) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
5WL_Lateral(L5WL) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
5WL_Caudal(Cd5WL) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
5WL_Medial(M5WL) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
Cr2WL-Cr5WL .7732 .0000 .2969 .0449 
L2WL-L5WL .0181 .0000 .0224 .0002 
Cd2WL-Cd5WL .0462 .0000 .1165 .0039 
M2WL-M5WL .3161 .0001 .5431 .0073 
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Table 62.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Cranial(Cr2WL) 141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
2WL_Lateral(L2WL) 120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
2WL_Caudal(Cd2WL) 112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
2WL_Medial(M2WL) 102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
5WL_Cranial(Cr5WL) 230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
5WL_Lateral(L5WL) 245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
5WL_Caudal(Cd5WL) 220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
5WL_Medial(M5WL) 205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
Cr2WL-Cr5WL .2893 .1526 .9879 .0079 
L2WL-L5WL .0451 .0025 .4919 .0000 
Cd2WL-Cd5WL .1178 .0060 .9230 .0012 
M2WL-M5WL .1481 .0347 .9967 .0012 
 
Table 63.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between left tibias loaded for 2 weeks and left tibias loaded for 5 weeks.  Standard 
deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 123.53(42.6) 37.06(8.04) 262.57(50.0) 51.66(3.72) 
2WL_Midshaft(MS2WL) 129.12(48.0) 36.67(2.95) 206.56(90.3) 44.08(9.63) 
2WL_Proximal(P2WL) 123.56(29.8) 37.90(4.46) 198.71(65.2) 48.65(9.80) 
5WL_Distal(D5WL) 225.88(41.0) 57.08(5.41) 302.42(19.36) 64.32(2.00) 
5WL_Midshaft(MS5WL) 272.75(68.7) 62.78(3.77) 377.70(52.9) 64.97(3.61) 
5WL_Proximal(P5WL) 214.44(24.9) 57.78(2.74) 298.83(49.0) 62.82(3.85) 
D2WL-D5WL .0508 .0001 .8858 .0251 
MS2WL-MS5WL .0031 .0000 .0018 .0002 
P2WL-P5WL .1023 .0001 .1168 .0101 
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Table 64.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Cranial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 141.53(24.6) 43.01(11.61) 290.43(47.3) 56.72(4.66) 
2WL_Midshaft(MS2WL) 169.52(67.1) 40.59(4.18) 236.57(68.0) 49.54(8.58) 
2WL_Proximal(P2WL) 139.26(26.7) 42.49(4.23) 248.18(118.) 54.36(14.24) 
5WL_Distal(D5WL) 230.93(44.9) 58.54(6.44) 321.50(31.1) 67.85(1.45) 
5WL_Midshaft(MS5WL) 255.87(71.0) 62.48(4.44) 392.50(54.7) 67.41(3.49) 
5WL_Proximal(P5WL) 222.01(28.9) 58.68(4.20) 331.65(49.7) 66.40(2.15) 
D2WL-D5WL .1512 .0142 .9742 .1078 
MS2WL-MS5WL .1766 .0004 .0139 .0030 
P2WL-P5WL .2110 .0100 .3792 .0694 
 
Table 65.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Lateral Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 120.86(64.2) 31.75(12.99) 196.34(23.2) 40.67(1.78) 
2WL_Midshaft(MS2WL) 71.92(34.1) 25.75(6.21) 109.51(53.8) 28.75(8.46) 
2WL_Proximal(P2WL) 73.68(47.6) 22.37(3.88) 113.62(61.2) 30.82(12.34) 
5WL_Distal(D5WL) 245.40(77.7) 57.22(6.52) 269.62(68.5) 58.67(2.89) 
5WL_Midshaft(MS5WL) 277.99(81.8) 64.35(5.50) 348.03(102.4) 58.25(7.78) 
5WL_Proximal(P5WL) 173.98(25.0) 52.43(4.98) 198.41(64.5) 47.12(11.49) 
D2WL-D5WL .0928 .0003 .7122 .0583 
MS2WL-MS5WL .0016 .0000 .0017 .0007 
P2WL-P5WL .2487 .0000 .5776 .1033 
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Table 66.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Caudal Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 112.62(62.2) 32.43(10.07) 256.25(35.3) 50.03(3.32) 
2WL_Midshaft(MS2WL) 104.01(55.5) 33.25(8.37) 192.70(114.6) 40.36(10.8) 
2WL_Proximal(P2WL) 119.79(25.9) 35.97(4.43) 185.28(30.6) 46.44(8.26) 
5WL_Distal(D5WL) 220.42(48.0) 55.96(6.80) 300.20(14.07) 63.22(4.82) 
5WL_Midshaft(MS5WL) 287.88(68.9) 62.29(3.30) 382.38(54.9) 63.60(5.68) 
5WL_Proximal(P5WL) 210.18(18.24) 56.97(4.00) 309.71(40.4) 64.43(5.67) 
D2WL-D5WL .0576 .0002 .8239 .0693 
MS2WL-MS5WL .0005 .0000 .0004 .0005 
P2WL-P5WL .1501 .0008 .0255 .0067 
 
Table 67.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and 
left tibias loaded for 5 weeks.  Standard deviations in parentheses. 
 
2 Week Loaded/5 Week Loaded Medial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptoti
c 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WL_Distal(D2WL) 102.34(18.4) 37.39(6.00) 284.29(112.9) 53.44(8.14) 
2WL_Midshaft(MS2WL) 157.92(62.4) 41.00(2.56) 256.64(168.4) 46.93(14.93) 
2WL_Proximal(P2WL) 178.15(40.5) 51.88(6.50) 193.30(62.0) 54.82(17.6) 
5WL_Distal(D5WL) 205.80(43.4) 56.84(7.32) 309.30(47.7) 66.62(3.26) 
5WL_Midshaft(MS5WL) 287.24(114.6) 60.99(5.37) 383.97(112.5) 68.84(5.07) 
5WL_Proximal(P5WL) 277.59(80.9) 63.09(4.59) 307.77(63.3) 66.61(4.91) 
D2WL-D5WL .4075 .0012 .9989 .2769 
MS2WL-MS5WL .1929 .0009 .4179 .0158 
P2WL-P5WL .4495 .1018 .5305 .3900 
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3.8 Comparison Between 2 Week and 5 Week Unloaded Right Tibia Controls 
 
 Below are the statistics for all of the 2 week unloaded right tibias compared 
against all of the 5 week unloaded right tibias used as controls, including a summary, 
analysis by quadrant, analysis by region and combinations of the latter two. For each 
statistical analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable 
osteocyte density and percentage of viable osteocytes were the variables considered. 
Mean values, standard deviations and relevant p-values are shown, with p-values less 
than 0.05 indicating statistically significant data. No statistically significant differences 
were seen between the 2 week unloaded controls and the 5 week unloaded controls. 
 
Table 68.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte 
density,  percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between right tibias unloaded for 2 weeks and right tibias unloaded for 5 weeks 
both used as controls.  Standard deviations in parentheses. 
 
2 Week Control/5 Week Control Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Cranial(Cr2WR) 128.08(34.1) 36.20(2.08) 305.68(62.2) 59.06(6.36) 
2WR_Lateral(L2WR) 107.65(31.1) 28.30(3.83) 242.22(34.7) 46.37(1.55) 
2WR_Caudal(Cd2WR) 112.28(33.9) 30.21(2.91) 277.54(52.9) 52.05(5.01) 
2WR_Medial(M2WR) 167.96(40.6) 38.92(4.06) 344.32(35.6) 61.03(6.19) 
5WR_Cranial(Cr5WR) 151.11(17.04) 41.24(4.74) 358.88(83.2) 66.72(3.11) 
5WR_Lateral(L5WR) 154.51(36.2) 36.82(6.58) 319.53(27.5) 57.41(10.05) 
5WR_Caudal(Cd5WR) 141.49(28.4) 37.35(6.70) 368.86(59.6) 64.33(7.15) 
5WR_Medial(M5WR) 154.90(45.1) 38.35(6.07) 336.28(58.0) 64.63(6.75) 
Cr2WR-Cr5WR .9761 .8859 .8845 .7336 
L2WR-L5WR .5253 .3711 .5528 .3097 
Cd2WR-Cd5WR .9187 .5882 .3482 .1981 
M2WR-M5WR .9992 1.0000 1.0000 .9939 
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Table 69.  Mean quadrantal data gathered from the proximal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Proximal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Cranial(Cr2WR) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
2WR_Lateral(L2WR) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
2WR_Caudal(Cd2WR) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
2WR_Medial(M2WR) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
5WR_Cranial(Cr5WR) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
5WR_Lateral(L5WR) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
5WR_Caudal(Cd5WR) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
5WR_Medial(M5WR) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
Cr2WR-Cr5WR .9377 .9849 1.0000 .9989 
L2WR-L5WR .1674 .0578 .8654 .4522 
Cd2WR-Cd5WR .6987 .5552 .5660 .1703 
M2WR-M5WR 1.0000 1.0000 .9874 1.0000 
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Table 70.  Mean quadrantal data gathered from the midshaft region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Midshaft Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptoti
c 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Cranial(Cr2WR) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
2WR_Lateral(L2WR) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
2WR_Caudal(Cd2WR) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
2WR_Medial(M2WR) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
5WR_Cranial(Cr5WR) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
5WR_Lateral(L5WR) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
5WR_Caudal(Cd5WR) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
5WR_Medial(M5WR) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
Cr2WR-Cr5WR .9642 .9894 .6615 .6854 
L2WR-L5WR .2220 .4034 .5735 .0798 
Cd2WR-Cd5WR .8821 .6009 .5851 .0796 
M2WR-M5WR .9990 1.0000 1.0000 .9999 
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Table 71.  Mean quadrantal data gathered from the distal region for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Distal Quadrant 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Cranial(Cr2WR) 131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
2WR_Lateral(L2WR) 143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
2WR_Caudal(Cd2WR) 133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
2WR_Medial(M2WR) 162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
5WR_Cranial(Cr5WR) 138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
5WR_Lateral(L5WR) 136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
5WR_Caudal(Cd5WR) 136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
5WR_Medial(M5WR) 144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
Cr2WR-Cr5WR 1.0000 .9534 .9882 .6046 
L2WR-L5WR 1.0000 1.0000 .9970 .9886 
Cd2WR-Cd5WR 1.0000 .9996 .9720 .9902 
M2WR-M5WR .9996 1.0000 .9873 .9047 
 
Table 72.  Regional differences of apoptotic osteocyte density, viable osteocyte 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
between right tibias unloaded for 2 weeks and right tibias unloaded for 5 weeks 
both used as controls.  Standard deviations in parentheses. 
 
2 Week Control/5 Week Control Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Distal(D2WR) 138.65(49.4) 34.19(4.82) 305.10(61.4) 57.41(8.62) 
2WR_Midshaft(MS2WR) 127.87(47.9) 33.16(5.05) 290.88(76.4) 54.39(2.97) 
2WR_Proximal(P2WR) 103.63(11.37) 32.90(1.36) 271.71(21.5) 53.92(1.24) 
5WR_Distal(D5WR) 139.09(45.8) 37.63(8.96) 350.68(71.9) 64.41(7.51) 
5WR_Midshaft(MS5WR) 163.32(22.7) 39.67(7.46) 394.35(83.1) 64.55(5.68) 
5WR_Proximal(P5WR) 142.64(22.93) 39.58(5.51) 307.31(69.6) 62.56(6.33) 
D2WR-D5WR 1.0000 .9760 .9389 .6117 
MS2WR-MS5WR .7029 .7366 .3385 .2339 
P2WR-P5WR .6161 .7174 .9782 .3943 
 
  
78 
 
Table 73.  Mean regional data gathered from the cranial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Cranial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Distal(D2WR) 131.09(54.8) 34.08(3.96) 311.52(82.5) 57.40(11.25) 
2WR_Midshaft(MS2WR) 133.45(46.1) 36.55(6.04) 291.28(113.2) 58.95(7.50) 
2WR_Proximal(P2WR) 119.69(7.01) 37.96(2.02) 314.25(20.9) 60.82(0.92) 
5WR_Distal(D5WR) 138.46(35.3) 40.80(10.09) 354.90(89.4) 68.47(6.75) 
5WR_Midshaft(MS5WR) 164.57(27.5) 40.87(7.98) 408.90(123.1) 67.21(4.17) 
5WR_Proximal(P5WR) 150.31(18.42) 42.06(4.85) 312.83(88.0) 64.48(3.61) 
D2WR-D5WR .9995 .7607 .9867 .1349 
MS2WR-MS5WR .7505 .9518 .5296 .3976 
P2WR-P5WR .7624 .9613 1.0000 .9500 
 
Table 74.  Mean regional data gathered from the lateral quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Lateral Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Distal(D2WR) 143.13(36.0) 35.72(5.44) 293.43(67.2) 54.09(9.46) 
2WR_Midshaft(MS2WR) 115.74(41.0) 28.43(7.06) 238.32(27.8) 43.87(1.80) 
2WR_Proximal(P2WR) 64.08(23.4) 20.74(2.88) 194.92(47.2) 41.14(7.09) 
5WR_Distal(D5WR) 136.41(26.3) 35.30(6.60) 328.00(64.6) 59.19(9.15) 
5WR_Midshaft(MS5WR) 191.78(69.1) 39.62(8.77) 365.40(99.9) 58.69(11.38) 
5WR_Proximal(P5WR) 135.35(48.8) 35.54(8.14) 265.19(37.4) 54.35(11.81) 
D2WR-D5WR .9999 1.0000 .9751 .9758 
MS2WR-MS5WR .2412 .2886 .1164 .3144 
P2WR-P5WR .3025 .0830 .6711 .4351 
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Table 75.  Mean regional data gathered from the caudal quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Caudal Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Distal(D2WR) 133.58(57.0) 31.55(5.84) 309.09(48.5) 56.91(6.88) 
2WR_Midshaft(MS2WR) 115.72(46.9) 29.34(5.27) 270.63(79.6) 49.77(3.04) 
2WR_Proximal(P2WR) 87.54(4.45) 29.74(1.01) 252.90(52.5) 49.47(5.94) 
5WR_Distal(D5WR) 136.99(60.2) 34.62(10.86) 359.66(81.8) 61.89(9.12) 
5WR_Midshaft(MS5WR) 155.41(25.9) 38.86(7.33) 396.47(83.9) 64.60(6.96) 
5WR_Proximal(P5WR) 132.08(25.1) 38.56(6.21) 350.45(97.9) 66.50(9.72) 
D2WR-D5WR 1.0000 .9913 .9478 .9449 
MS2WR-MS5WR .7471 .4870 .2861 .1285 
P2WR-P5WR .6499 .5668 .5509 .0594 
 
Table 76.  Mean regional data gathered from the medial quadrant for apoptotic 
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks 
and right tibias unloaded for 5 weeks both used as controls.  Standard deviations in 
parentheses. 
 
2 Week Control/5 Week Control Medial Region 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
2WR_Distal(D2WR) 162.81(42.1) 39.17(3.84) 298.90(38.3) 61.43(6.88) 
2WR_Midshaft(MS2WR) 172.28(58.3) 37.96(6.36) 421.17(65.7) 63.17(4.14) 
2WR_Proximal(P2WR) 168.77(35.7) 39.63(4.38) 312.88(92.7) 58.51(13.4) 
5WR_Distal(D5WR) 144.39(79.4) 39.21(11.13) 342.81(65.2) 69.06(8.48) 
5WR_Midshaft(MS5WR) 155.11(10.82) 37.32(6.66) 397.45(95.8) 65.21(5.78) 
5WR_Proximal(P5WR) 165.20(61.2) 38.51(9.86) 268.59(73.3) 59.62(9.94) 
D2WR-D5WR .9966 1.0000 .9621 .7958 
MS2WR-MS5WR .9976 1.0000 .9976 .9993 
P2WR-P5WR 1.0000 1.0000 .9607 1.0000 
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4. DISCUSSION 
 
The goal of this study was to try to find a correlation between osteocyte apoptosis 
and the amount of cyclical loading applied, or lack thereof, in order to show that 
apoptotic osteocytes may be an important signaling factor in the bone remodeling 
process.  For this study, mice were procured and used due to their easy availability, 
affordability, and size, making them relatively easy to handle. Three mice were cyclically 
loaded for two weeks and six mice were cyclically loaded for 5 weeks, where the right 
hindlimb of each mouse was used as a control and the left hindlimb was cyclically 
loaded. Hindlimbs were used as opposed to forelimbs due to their larger cross sectional 
area and ability to be cyclically loaded with ease in the loading fixture utilized in this 
study. After the tibias were resected, processed, and sectioned with a microtome, each 
section was stained using a TUNEL assay, to detect apoptotic osteocytes, and 
counterstained with methyl green to detect viable osteocytes.  The density of apoptotic 
osteocytes was measured by region (proximal, midshaft, and distal) and quadrant (cranial, 
caudal, lateral, and medial) in loaded and unloaded murine cortical bone.  The percent of 
apoptotic osteocytes, density of viable osteocytes and percent of viable osteocytes were 
also similarly quantified. Statistical analyses were performed on all loaded and unloaded 
samples independently of each other as well as compared against each other in order to 
find any statistically significant data. Samples were analyzed by comparing quadrants, 
averaged across all regions and then isolated to each individual region as well, and then 
by comparing regions, averaged across all quadrants as well as isolated to each individual 
quadrant. In this study, it was hypothesized that higher amounts of apoptotic osteocytes 
would be seen in bones that were cyclically loaded when compared against unloaded 
bones, with the highest amount seen in the 5 week loaded bones. It was also hypothesized 
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that more pronounced regional variation would be seen in the 5 week loaded samples 
compared to the 2 week loaded samples as a result of the additional loading that they 
experienced. 
Looking, individually, at each type of bone analyzed in this study, 2 week loaded, 
2 week unloaded, 5 week loaded and 5 week unloaded, a number of trends and 
statistically significant information could be seen. As a general trend, 2 week loaded 
bones had densities and percentages of both viable and apoptotic osteocytes that were 
much lower in the lateral quadrant and slightly lower in the caudal quadrant, when both 
were compared to the other two quadrants. This trend was generally strongest in the 
proximal region for apoptotic osteocytes and strongest in the distal region for viable 
osteocytes. Similarly, for 2 week unloaded bones, viable and apoptotic osteocytes were 
much lower in the lateral quadrant and slightly lower in the caudal quadrant, when 
compared to the other two quadrants, with this trend being the strongest in the proximal 
region for apoptotic osteocytes and strongest in the midshaft for viable osteocytes. 
Generally, 5 week loaded bone showed lower viable osteocytes in the lateral quadrant, 
compared to the other quadrants, with this trend being strongest in the proximal region. 
Another general trend for 5 week loaded bone was that higher apoptotic and viable 
osteocytes were seen in the midshafts compared to the other regions, when averaged 
across all quadrants. No trends and only one statistically significant difference was seen 
within the 5 week unloaded bone data; when looking only within the medial quadrant, a 
higher density of viable osteocytes were seen in the midshaft compared to the proximal 
region. Overall, 5 week loaded samples showed the most variation within themselves 
with 24 significant p-values found in the analysis. 
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Comparing the results from this study to the data presented in a similar previous 
study, by Jessica Chan, yields some similarities (Chan 2011). No cyclical loading, 
however, was performed in the latter study and, thus, only data from individual control 
samples in this study can be compared to the data presented in her study. In both studies, 
there weren't a lot of statistically significant findings, when looking solely at differences 
within unloaded bone samples.  However, when analyzing samples by quadrant, the 
current study showed some general trends, with some statistically significant p-values, of 
lower apoptotic and viable osteocyte values in the lateral and caudal quadrants when 
compared to the other quadrants. Jessica's research showed a similar trend for the 
apoptotic and viable osteocyte densities, although no statistically significant p-values 
were found to support this trend in her study. Only a few statistically significant 
differences were found in Jessica's study; midshafts were shown to have higher viable 
and apoptotic osteocytes when compared to the other regions. In the current study, 
although not seen in 2 week samples, this trend was similarly observed within the 5 week 
loaded and unloaded samples, with statistically significant p-values only seen in the 5 
week loaded samples. Differences observed between the samples used in this study and 
the samples from Jessica's study may be due to the fact that a lower quantity of mice that 
were younger in age, and possibly skeletal maturity, were used in the study performed by 
her. Overall, given that the samples analyzed in Jessica's study only yielded some 
statistically significant p-values when looking at the midshafts, and nowhere else, the 
most prevalent trend between samples used in both studies is the general lack of 
statistically significant findings seen for unloaded bone samples. This should then 
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provide some evidence that the control samples in this study and the samples used in 
Jessica's study are relatively similar (Chan 2011). 
In order to shed more light on the role of apoptotic osteocytes in the remodeling 
process, statistical analyses comparing each type of sample, loaded and unloaded, to one 
another is necessary. The first comparison analyzed in this study was 2 week loaded 
samples against 2 week unloaded control samples. When comparing 2 week loaded bones 
samples against 2 week unloaded control samples, only one statistically significant 
difference was found; the percentage of apoptotic osteocytes in 2 week loaded samples 
was shown to be higher than the 2 week unloaded bones when analyzed within the medial 
quadrant of the proximal region. Overall, the 2 week loaded samples showed little 
statistically significant differences to the unloaded samples. However, 2 week loaded 
bones showed a trend of slightly more apoptotic osteocytes and less viable osteocytes 
than 2 week control samples, even though there weren't any statistically significant p-
values to support this trend. This could be because 2 weeks is only enough time to reach 
the start of the remodeling process. A study by Noble et al. showed that load induced 
DNA damage is followed by cellular apoptosis process within 2 weeks of initial damage 
stimulus (Noble, et al. 2003). In the study, at 14 days after loading, less cells with DNA 
fragmentation and less viable cells were observed as well as the first signs of Haversion 
remodeling (Noble, et al. 2003). This observation from Noble's study could explain the 
general trend of slightly more apoptotic osteocytes, less viable osteocytes and overall 
lack of statistically significant differences seen in this study's samples loaded for 2 
weeks, when compared to the controls. 5 week unloaded and 2 week unloaded samples 
were also compared against one another. As expected, the 2 week unloaded and 5 week 
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unloaded samples showed no statistically significant differences when compared against 
each other. Given that the samples cyclically loaded for the most amount of time were 
expected to show the most differences when compared against unloaded samples, 5 week 
loaded samples were compared against both 5 week unloaded and 2 week loaded 
samples. 
As previously mentioned before, no significant differences were found between 2 
week loaded samples and 2 week unloaded samples nor between 2 week unloaded 
samples and 5 week unloaded samples. It makes sense, then, that comparing 5 week 
loaded samples against both 5 week unloaded samples and 2 week loaded samples 
yielded many similarities. Except for two statistically insignificant p-values when 
compared with 2 week loaded samples, all locations within 5 week loaded samples 
showed significantly higher percentages of apoptotic osteocytes than those of both the 5 
week unloaded samples and the 2 week loaded samples, when averaged across all 
regions, averaged across all quadrants and when isolated to each individual region or 
quadrant. Including p-values of .0565 or less, 5 week loaded samples showed statistically 
higher densities of apoptotic osteocytes than 5 week unloaded control samples for each 
quadrant, when averaged across all regions, and for each region, when averaged across all 
quadrants and when looking at the cranial and caudal quadrants individually. For 2 week 
loaded versus 5 week loaded samples, all 5 week loaded quadrants, except the cranial 
quadrant, showed higher densities of apoptotic osteocytes, when averaged across all 
regions. Also, densities of apoptotic osteocytes were higher in 5 week loaded midshafts, 
when averaged across all quadrants and when analyzed in the caudal or lateral quadrants 
individually. The percentage of viable osteocytes in 5 week loaded bones was 
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significantly higher than in 2 week loaded bones for all quadrants, when averaged across 
all regions, and in all regions, when averaged across all quadrants. 
Fitting with this study's hypothesis, 5 week loaded samples showed the biggest 
differences when compared with all other samples, especially in terms of the density and 
percentage of apoptotic osteocytes present. Statistically significant values, indicating that 
each quadrant and region in 5 week loaded samples had a higher percentage of apoptotic 
osteocytes than any other sample group, provides strong evidence in support of increased 
apoptosis and regional variations in samples that are cyclically loaded. 5 week loaded 
samples also showed an increase in the density of apoptotic osteocytes, but not to the 
same magnitude that the percent of apoptotic osteocytes data showed. There were also 
many statistically significant regions and quadrants showing increased viable osteocytes 
in 5 week loaded samples compared to 2 week loaded samples. This difference was not 
also observed between 5 week loaded samples and the controls because the difference 
appears to be due to the specific time points in which the two difference loading groups 
were loaded and subsequently sacrificed. As previously discussed, the 2 week loaded 
samples may have shown slightly more apoptotic osteocytes and less viable osteocytes 
than 2 week unloaded samples because, as described by Noble, samples exhibited less 
apoptotic and viable osteocytes as well as the first signs of remodeling at 14 days after 
the initial damage stimulus from loading. In the same study by Noble et al., at 7 days 
after loading, more osteocytes with DNA fragmentation and similar viable osteocytes, 
when compared to the control samples, were seen (Noble, et al. 2003). These two 
observations, from Noble's study, help shed light on why statistically significant 
differences in the amount of viable osteocytes were only observed between 5 week and 2 
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week loaded samples. All of these previously discussed trends involving the 5 week 
loaded samples, showing increased values apoptotic and viable osteocyte values in these 
samples, are further strengthened by the fact that no significant trends were observed 
when comparing the 2 week unloaded samples against both the 2 week loaded and 5 
week unloaded samples, thus agreeing with the rationalizations given in this discussion as 
well as the observations presented here from other studies; only 5 week loaded samples, 
in this study, showed multiple statistically significant differences to other samples.  
The results from this study were focused on quantifying variations in the amount 
of apoptotic osteocytes present in loaded mice hindlimbs, unloaded mice hindlimbs and 
any differences there may be between the two, in an attempt to better explain the 
mechanisms and factors in which bone remodeling is initiated. Bones repair and replace 
themselves in response to the specific mechanical loads that they experience throughout 
each region (Noble, et al. 2003). How bones specifically use this information has been a 
question that has attempted to be answered by various theories, one of which involves 
naming apoptotic osteocytes as the signaling mechanism in which osteoblasts and 
osteoclasts are targeted, as necessary. The data from this study did in fact support the 
hypothesis that osteocyte apoptosis was increased and regional variations were enhanced 
due to cyclical loading applied to murine tibias. Other research has similarly made 
observations about bone remodeling and osteocyte apoptosis.  One study, by Noble et al., 
demonstrated a U-shaped correlation with osteocyte apoptosis and bone loading, with 
disuse and fatigue loading microdamage showing increased apoptosis (Noble, et al. 
2003). A study by Verborgt et al. showed that microdamage caused by fatigue loading 
showed increased levels of apoptotic osteocytes, especially concentrated around the 
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regions with microdamage or resorption (Verborgt, et al. 2000). Another study, by 
Cardoso et al., showed similar results indicating how apoptotic osteocytes are temporally 
and spatially linked to fatigue induced microdamage and the intracortical bone 
remodeling that follows (Cardoso, et al. 2009). A study by Hedgecock et al. showed a 
strong correlation between apoptotic osteocytes and remodeling parameters (Hedgecock, 
et al. 2007). In the same study, the researchers stated that their approximation of viable 
osteocytes showed no linear correlation with any of the remodeling or modeling factors 
studied (Hedgecock, et al. 2007). Although there is still much information lacking, 
especially in terms of the specific cellular interactions and communication networks at 
play from the beginning initiation of the remodeling process to the end of it, it is the hope 
of this study that the data analyzed and discussed within joins the previously mentioned 
studies in providing evidence in support of the role that apoptotic osteocytes must play in 
the remodeling process. 
4.1 Limitations 
 Despite being a continuation of a previous study (Chan 2011), there are many 
limitations to the current study. Firstly, efforts were put forth to maintain all mice under 
the same day to day conditions by giving them similar living, dietary and loading 
conditions. However, as the mice were allowed to move around day to day, when not 
being loaded, there may have been some differences in the amount of exercise that each 
mouse received. Secondly, even though care was taken to ensure consistency from 
sample to sample when taking cross-sectional slices from the distal, midshaft and 
proximal regions of each sample, the location within each region that sample was taken 
from may have been different from subject to subject, which may cause unwanted 
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differences when analyzing the data. In regards to the TUNEL and methyl green staining, 
best efforts were put forth to use the same staining procedure with all samples for 
equivalency, however, some samples showed clearer color, indicating that the staining in 
some samples may have been better than others; TUNEL staining may also be subject to 
false staining which may have affected some of the counted data. In order to perform the 
TUNEL and methyl green staining, two adjacent samples were cut and the TUNEL stain 
was applied to one sample while the methyl green was applied to the other. Although this 
eliminated some of the problems encountered with co-staining, the two adjacent samples 
used may not have been entirely similar, which could have caused more unwanted 
differences or discrepancies in the data analysis. Also, by not co-staining the two 
methods together, the TUNEL stain may have incorrectly stained non-apoptotic 
osteocytes that contain DNA breaks, which was not accounted for in this study 
(Hedgecock, et al. 2007).When counting the amount of apoptotic and viable osteocytes 
present in each sample, there may have been some error in the actual values counted as 
this was done one by one by a single person, which leaves room for potential error.  
4.2 Applications and Future Work  
Experiments such as the current study provide more information surrounding 
apoptotic osteocytes and their role in the bone remodeling process. The results from this 
study give support to the idea that apoptotic osteocytes play an important role in bone 
remodeling and give data showing differences between unloaded and loaded bones in 
terms of apoptotic osteocytes. Future work should be performed to further look at the 
effects that apoptotic osteocytes have on neighboring cells and communication networks. 
This may include looking deeper into any signaling, an example being osteoclastogenic 
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signaling, that may be occurring between other neighboring osteocytes, both apoptotic 
and non-apoptotic, as well as any spatial or temporal patterns between the cells present 
while various types of remodeling communication is occurring.  
4.3 Conclusion 
 This study set out to demonstrate regional and quadrant differences, namely 
increases in the number of apoptotic and viable osteocytes, in cyclically loaded murine 
tibiae when compared with unloaded bones in attempt to provide evidence in support of 
apoptotic osteocytes playing a role in the remodeling process. The results of this study 
showed increased apoptotic osteocytes, both in percentage and density, for the 5 week 
loaded samples when compared against the unloaded controls as well as the 2 week 
loaded bones. An increased percentage of viable osteocytes was also observed in the 5 
week loaded bones when compared with the 2 week loaded samples. Individually, 5 week 
loaded samples also showed the most enhanced regional variation. Overall, 5 week 
samples showed an increase in apoptotic osteocytes as well as the most regional and 
quadrantal variation when compared against all other samples, thus, supporting our initial 
hypothesis and providing evidence in support of apoptotic osteocytes playing a role in the 
remodeling process. Further research that delves into the specific mechanisms of how 
apoptotic osteocytes help initialize bone remodeling as well as other potential localized 
interactions or communication that apoptotic osteocytes provide will further our 
understanding of the human body and the bone remodeling process. 
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APPENDICES 
 
Appendix A 
 
Mice Loading Protocol 
 
Equipment needed: 
Bose Enduratec 3220 
Load cell 
Wintest PCI control system 
Enduratec signal box 
Mouse fixture with weights 
Surgical tape 
Q-tips 
Procedure: 
1) Turn on the Enduratec signal box, Wintest PCI control system and the computer. 
2) Open the program: WinTest 
3) File Open Project  05-177 Cal poly pchang test.prj 
4) Setup  Limits Display check limits (ensure that fixture will not hit bottom of the 
plunger) 
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5) Setup Channels Autotare 
 
6) Feedback Set axial feedback to displacement 
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7) LocalHigh (means displacement can be adjusted live) 
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8) Click position button raise so that the mouse can fit underneath the plunger 
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9) Ensure that nose cone is fasten securely with the chemistry stand and that it is not 
touching the fixture. Chemistry stand should be secured to the table with C-clamps. 
10) Set up the isoflurane anesthesia machine so that it is connected to the anesthesia 
chamber but readily available to be connected to the nose cone tubing. 
11) In the chamber, 4.5% isoflurane should be release at 3L/min. 
12) Place a piece of surgical tape on the forelimbs of the mouse. 
13) Once anesthetized in the chamber, the chamber tubing should be switched with the 
nose cone tubing and the anesthesia machine should be set to 2% isoflurane at 1L/min. 
14) The mouse is then placed on top of the ramp fixture. 
15) Ensure that the nose of the mouse is secured in the nose cone (use the pieces of the 
tape on the forelimbs to help secure the nose location). 
16) Put left heel of the mouse into the groove on the ramp fixture. Use a piece of surgical 
tape to secure the foot down. 
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17) Lower the plunger position slowly until a force of -0.04 N is achieved. Use the q-tip 
to push the top of the femur so that the knee joint is fully constrained by the plunger cup 
indentation.  
18) Click waveform block signal tab peak/valley browsename the file. 
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19) Click the scope for group 1 eraser icon 
 
20) Hit the disk icon save scope export file (turns yellow) 
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21) Click on run zero start 
 
 
 
22) Once it finishes, click the disk icon again and name the file. 
23) Click the position icon  raise the plunger until the mouse 
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Appendix B 
 
Microtome Protocol 
 
1) Put paraffin embed sample block(s) in the refrigerator for at least 30 minutes.  
2) Wash hands and water bath with soap (try not to get the front of the water bath wet). 
3) Dry with paper towels. 
4) Put gloves on. 
5) Fill water bath with distilled water. 
6) Write name in the logbook. 
7) Use the lever to secure wax block in the holding mechanism. 
8) Insert the blade into the designated slot and lightly tighten until secure. 
9) Release the handle lock on the right side of the microtome. 
10) Push the base, holding the blade, up to the tissue block and lock in place. 
11) Set the microtome to 20 µm and face the block a few times to take off the top layers 
of wax and reveal the bone. 
12) Set the microtome to 7 µm and cut sections as needed. 
13) Use the tweezers to carefully carry and place the sections in the water bath 
14) Use blunt dissection cuts to separate individual sections so they fit on a microscope 
slide. 
15) Angle the microscope slide into the water below the sections and raise it slowly to the 
surface ensuring that the section gets carefully placed onto the microscope (be sure that 
the microscope slide is oriented properly so that it can still be written on and labeled). 
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Appendix C 
 
TUNEL and Methyl Green Staining Procedures 
 
TUNEL Staining Procedure 
1. Deparaffinize the tissue sections 
 Immerse the slides in xylene for 5 minutes 
2. Immerse in 100% ethanol for 8 minutes (wash) 
3. Rehydrate through graded ethanol washes 
 95% ethanol for 3 minutes 
 85% ethanol for 3 minutes 
 70% ethanol for 3 minutes 
 50% ethanol for 3 minutes 
4. Air dry for 20 minutes 
5. Immerse in PBS for 5 minutes (wash) 
6. Immerse in HistoChoice for 15 minutes (fix)  
7. Immerse in PBS for 10 minutes (wash) 
8. Remove liquid from tissue and place slides on a flat surface 
 Prepare a 20 µg/ml proteinase k solution:  
  1 part 10 mg/ml proteinase k stock solution (see Appendix for procedure) 
  to 
  499 parts PBS 
Add 100 µL of the proteinase k solution to each slide to cover the tissue section 
Incubate slides for 10 to 30 minutes (set out to dry) 
Use shorter incubation times because of the thinner sections. 
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9. Immerse in PBS for 5 minutes (wash) 
10. Immerse in HistoChoice for 5 minutes (refix) 
11. Immerse in PBS for 5 minutes (wash) 
For positive control: treat sample with DNase I  causes DNA fragmentation 
12. Tap the slides to remove excess liquid (use Kimwipes) 
Cover the cells with 100 µL of equilibration buffer 
Equilibrate for 5 to 10 minutes 
13. Thaw biotinylated nucleotide mixture on ice 
Prepare rTdT reaction mixture, keep on ice 
100 µL of the reaction mixture per slide will be enough to cover the section 
For positive control: 
Combine: 98 µL of equilibration buffer 
  1 µL of biotinylated nucleotide mixture 
  1 µL of rTdT 
14. Blot around equilibrated areas with tissue paper 
Add 100 µL of the rTdT reaction mixture to the sections on each slide 
Do not allow the sections to dry out 
15. Cover the sections with plastic coverslips to evenly distribute the reagent 
Incubate at 37 degrees C for 60 minutes inside of a humidified chamber (wet paper 
towel over dish) 
This step allows the end-labeling reaction to occur 
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16. Dilute:  1 part 20x SSC solution 
  to 
  10 parts deionized water 
Remove coverslips 
Immerse in the 2x SSC solution for 15 minutes 
This step terminates the end-labeling reaction 
17. Immerse in fresh PBS for 15 minutes (wash) 
This step removes unincorporated biotinylated nucleotides 
18. Dilute:  1 part 3% hydrogen peroxide 
  to 
  10 parts PBS 
Immerse in the 0.3% hydrogen peroxide solution for 3 to 5 minutes 
Do not use the 20x hydrogen peroxide 
This step blocks endogenous peroxidases 
19. Immerse in PBS for 15 minutes (wash) 
20. Dilute streptavidin HRP solution 1:500 in PBS 
Add 100 µL to each slide 
Incubate for 30 minutes (set out to air dry) 
21. Immerse in PBS for 15 minutes (wash) 
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22. Combine DAB components right before use 
Add 50 µL of DAB substrate 20x buffer to 950 µL of deionized water 
Add 50 µL of DAB chromagen and 50 µL of hydrogen peroxide 20x 
Add 100 µL of this DAB mixture to each slide and develop until there is a light 
brown background, approximately 20 minutes 
Keep DAB components and mixture away from light and use mixture within 30 minutes 
23. Rinse several times in deionized water 
24.  Mount slides with permount 
 
Methyl Green Staining Procedure 
1. Do steps 1 through 4 of TUNEL procedure 
To do simultaneously with the TUNEL procedure, offset the Methyl Green slides by 8 
minutes behind. 
2. Immerse in deionized water for 5 minutes 
3. Immerse in 2% Methyl Green for 45 seconds 
4. Rinse in distilled water 
5. Rinse in deionized water 
6. Mount slides with permount 
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Proteinase k Reconstitution Procedure 
Proteinase k comes in a powdered form and needs to be reconstituted with a proteinase k 
buffer solution. 
Proteinase k Buffer: 
100mM Tris-HCl (pH 8.0) 
50mM EDTA  
1. Micropipette 0.100 mL of 1M Tris-HCl (pH 8.0) into a 1 mL aliquot. 
2. Micropipette 0.100 mL of 0.5M EDTA (pH 8.0) into the aliquot. 
3. Bring the volume to 1 mL with deionized water. 
4. Mix 10 mg of the proteinase k powder with 1 mL of the buffer. 
This reconstituted proteinase k will be a 10mg/mL solution. 
